September 14-18 Barcelona, Spain CIRSE 2013 · Programme highlights include: Evidence Forums – new sessions devoted to evidence-based medicine. Forum topics will include the management

C RSECardiovascular and Interventional Radiological Society of Europe

PROGRAMMEREGISTRATIONTRAVEL

INNOVATIONTHE WAVE OF

September 14-18Barcelona, Spain

CIRSE 2013

The Second Announcement CIRSE 2013In case of any enquiries or comments, please contact us at [email protected]© Cardiovascular and Interventional Radiological Society of Europe / 2013

Graphic Design: LOOP.ENTERPRISES media EU www.loop-enterprises.comCover: Architectural detail of Casa Milà (1906-1910), Barcelona, Spain / Architect: Antoni Gaudi (1852-1926) Photo © DreamstimeP. 48: Photo © AlexRathsPrint: Druckerei Janetschek GmbH Heidenreichstein / Austria

General Information

Committees / Welcome Address

Excellence in Interventional Radiology

Dignitaries

CIRSE meets Singapore

Exhibitors

General Information

Registration

Accommodation

City Map

2 4 6 15 19 53 55 56 57

Contents

Scientific Programme

Preliminary Faculty

Main Themes

Session Types

Foundation Courses

Hot Topic Symposia

Evidence Forums

Foldout Timetable

Radiographer Programme

Programme

Hands-on Workshops

6,173 Participants

85 Countries

1,230 Abstracts

250 Hours of Education

115 Exhibitors

5,600 m² of Technical Exhibition

28th ANNuAL MEETING AND POSTGRADuATE COuRSE

www.cirse.org

Facts & Figures CIRSE 2012:

12 16 18 22 24 28 30 31 46

C RSE

2 Committees / Welcome Address

Executive Committee

Michael J. Lee (IE), PresidentAnna-Maria Belli (uK), Vice PresidentMario Bezzi (IT)Elias Brountzos (GR)Fabrizio Fanelli (IT)Patrick Haage (DE)Klaus A. Hausegger (AT)Riccardo Lencioni (IT)Jose J. Martínez Rodrigo (ES)Robert A. Morgan (UK)Jan H. Peregrin (CZ)Philippe L. Pereira (DE)Dimitrios K. Tsetis (GR)Dierk Vorwerk (DE)Daniel Waigl (AT)

Scientific Programme Committee

Robert A. Morgan (uK), ChairmanPatrick Haage (DE), Deputy ChairmanMario Bezzi (IT)Christoph A. Binkert (CH)Saruhan Cekirge (TR)Afshin Gangi (FR)Klaus A. Hausegger (AT)Alexis D. Kelekis (GR)Antonin Krajina (CZ)Michael J. Lee (IE)Riccardo Lencioni (IT)José J. Muñoz Ruiz-Canela (ES)Olivier Pellerin (FR)Otto M. van Delden (NL)

Local Host Committee

José J. Martínez Rodrigo (Valencia), Co-ChairmanJosé J. Muñoz Ruiz-Canela (Málaga), Co-ChairmanAnna Alguersuari (Sabadell)Roger Barranco Pons (Barcelona)Marta Barrufet (Barcelona)Javier Blazquez Sanchez (Madrid)Marta Burrel (Barcelona)Iratxe Díez Miranda (Barcelona)Joan F. Falco-Fages (Sabadell)Fernando M. Gómez (Valencia)Elena Lonjedo (Valencia)Teresa Moreno Sanchez (Huelva)Joan Perendreu (Sabadell)Mercedes Pérez Lafuente (Barcelona)José M. Rodriguez Mesa (Málaga)Antonio Segarra Medrano (Barcelona)

CIRSE Committees

3

Annual Meeting and Postgraduate Course

Dear Colleagues,

CIRSE is proud of its status as a European and global IR society, with members coming from all 5 continents. CIRSE’s involve-ment in many IR projects around the world lays a firm founda-tion for a strong and dynamic annual meeting. In staging CIRSE 2013, our intention is to further globalise both faculty and audience, helping to reaffirm our meeting’s position as a major platform for Interventional Radiology on a global scale.

CIRSE 2012 proved another great success, and the Scientific Programme Committee is hard at work to make sure CIRSE 2013 lives up to this standard. Feedback and evaluation forms from the meeting in Lisbon have been analysed and used to refine the scientific and educational menu we will be offering in Barcelona.

With this Second Announcement, we cordially invite you to make yourself familiar with the educational and scientific pro-gramme of CIRSE 2013. You will find new, cutting-edge topics have been added and more established sessions have been improved based on your feedback. We hope it meets your expectations!

Programme highlights include:

Evidence Forums – new sessions devoted to evidence-based medicine. Forum topics will include the management of SFA and BTK peripheral vascular disease, as well as HCC and colorectal metastases.

Hot Topic Symposia – dynamic sessions on two contemporary topics – interventional oncology in lung cancer and IR stroke management.

Controversy Sessions – lively debates covering the manage-ment of aortic disease, endoleaks, peripheral vascular interventions and portal hypertension.

Amazing Interventions – a new and exciting session featuring presentations on some of IRs most unusual cases by leading figures in the field.

Hands-on Workshops – emphasis will, once again, be placed on the ever-popular Hands-on Workshops and a new session dedicated to renal denervation will be introduced.

Last year’s congress saw the introduction of two major new features, the CIRSE digital App and the live stream from the main auditorium. The App proved a useful tool for congress attendees and was downloaded over 2,000 times, and over 500 unique users tuned into the live stream. Due to their clear popularity, both the CIRSE App and the live stream will also feature at CIRSE 2013.

Abstract submissions have remained high in recent years. For CIRSE 2013, we have received 1,360 abstracts: an all-time high and an increase of 20% compared to 2012.

The CIRSE Annual Meeting is now the largest IR congress in the world, drawing an attendance of over 6,000 delegates annually. Finding a congress centre that can accommodate this large number of attendees can, therefore, be a challenge. Fortunately, the Barcelona International Convention Centre fulfils all of our space criteria and we are delighted to have secured it for our congress. Barcelona is also a city that needs no introduction, providing the ideal infrastructure for large congresses as well as many other services catering to visitors.

With all this in mind, we cordially invite you to join us for the 28th Annual CIRSE Congress, which will take place in the cosmopolitan and inspirational city of Barcelona, Spain from 14-18 September, 2013.

We look forward to seeing you there!

Michael J. Lee CIRSE President

Robert A. MorganScientific Programme Committee Chairman

Patrick Haage Scientific Programme Committee Deputy Chairman

José J. Muñoz Ruiz-CanelaLocal Host Committee Co-Chairman

José J. Martínez Rodrigo Local Host Committee Co-Chairman

C RSE

4 Excellence in Interventional Radiology

CIRSE Gold Medallists

2013 J.I. Bilbao2012 P.R. Mueller2011 J.A. Reekers2010 F.S. Keller2009 J. Lammer2008 J.E. Abele, B. Cook2007 A. Adam2006 B.T. Katzen2005 J.F. Reidy2004 J.L. Struyven2003 C.L. Zollikofer2002 J.H. Göthlin, J.-J. Merland, E.P. Zeitler2001 E. Boijsen, F. Olbert, F. Pinet2000 P. Rossi1999 A.M. Lunderquist1998 D.J. Allison1997 R.W. Günther

CIRSE Distinguished Fellows

2013 J. Spies, B.S. Tan, P.R. Taylor2012 G.M. Richter, M. Szczerbo-Trojanowska, K.R. Thomson2011 J.A. Kaufman, L. Machan, A.F. Watkinson2010 O. Akhan, W.P.T.M. Mali2009 A.A. Nicholson, A.C. Roberts2008 K. Mathias, H.P. Rousseau2007 K.H. Barth, D.A. Kelekis2006 A. Rosenberger, G. Simonetti2005 F.S. Keller, A.J. Roche2004 A. Besim, B. Läubli, P.R. Mueller, R. Yamada2003 K. Hiramatsu, F. Joffre, H. Uchida2002 C. L‘Herminé, J.-M. Rius, M.R. Dean2001 J.-M. Bigot, J. Edgren2000 J.-C. Gaux, L. Horváth1999 U. Tylén1998 A.R. Essinger1997 J.H. Göthlin, J.L. Struyven1996 M.J. Amiel, P. Rossi1995 U. Erikson1994 D.J. Allison1993 E.P. Zeitler1992 I.P. Enge, A.M. Lunderquist, F. Olbert1991 A. Pinet, F. Pinet1990 A. Baert, L. Di Guglielmo, G. Van Andel1989 J.-L.M. Lamarque, R. Passariello1988 E. Boijsen, C.B.A.J. Puylaert, E. Voegeli

Gruentzig Lecture

2013 A. Holden2012 A. Gangi2011 J.G. Moss2010 D. Vorwerk2009 R. Lencioni2008 C. Becker2007 J.C. Palmaz2006 L. Solbiati2005 A.C. Roberts2004 E.P.K. Strecker2003 K.R. Thomson2002 P.A. Gaines2001 B.T. Katzen2000 J.L. Struyven1999 S. Wallace1998 R.W. Günther1997 P. Rossi1996 J. Rösch1995 D.J. Allison1994 E.P. Zeitler

Roesch Lecture

2013 M. Bezzi2012 D. Pavčnik2011 M. Szczerbo-Trojanowska2010 J.I. Bilbao2009 M.D. Dake2008 J.A. Kaufman2007 K. Ivancev2006 L. Machan2005 H.P. Rousseau2004 F.S. Keller2003 J. Rösch

Award of Excellence and Innovation in IR

2012 A. Bolia, J.A. Reekers

Excellence in Interventional Radiology

Please note that all applications must be submitted with a relevant CV or, in the case of research groups, a description of the members involved.

All applications must be submitted by June 14, 2013 to [email protected]. For more information, please visit the CIRSE website.

Innovation in IRThe Award of Excellence and

Innovative SpiritOn the occasion of CIRSE 2012, the R.W. Guenther Foundation honoured two ex cellent interventionists for their innovative work and dedication in establishing a new ground-breaking technique. Initially, subintimal angioplasty was met with strong criticism and resistance for many years, but today it is well accepted and has allowed many limbs to be saved from amputation.

DevelopmentMany dedicated physicians have shown this kind of perseverance, hard work and conviction, which has helped the relatively young medical field of IR to develop into the fully recognised subspecialty it is today. Without the continuous development and refinement of new devices and techniques by resourceful interventional radiologists, the ever-expanding range of treatments offered by our specialty would not have been possible.

RecognitionInnumerable patients are grateful for the wide range of minimally invasive alternatives to open surgery from which they can now benefit. Furthermore, CIRSE also wishes to honour your dedication and excellence in IR and present your innovation to the IR community during the opening ceremony of CIRSE 2013.

Recipients of this distinction will not only be awarded with a certificate of merit for their contributions to the field, but also a cash prize of € 5,000.

How to applySend us your groundbreaking research results, details of a novel technique you developed, or the cutting-edge equipment you have just patented. Our board of reviewers welcomes all your innovations and looks forward to the advances they may bring to IR.

R. W. Günther FoundationWe warmly thank the R.W. Günther Foundation for kindly sponsoring the award. The Foundation is based in Aachen, Germany and aims to promote science and research, especially in the field of radiological sciences and diagnostic and interventional radiology, as well as to support national and international co-operation.

6 Dignitaries

Distinguished FellowJames B. Spies

Dr. Spies is Professor and Chair in the Department of Radiology at Georgetown University Hospital in Washington DC. After attending Georgetown University School of Medicine, Dr. Spies completed a Radiology Residency at the University of California, San Francisco and a fellowship at New York University School of Medicine in Vascular and Interventional Radiology.

He served four years in the United States Air Force. After mili-tary service, he was in private practice for several years before joining the faculty of Georgetown University in 1997, when he became an associate professor of radiology. Dr. Spies received his professorship in 2003 and has served as chair of the Depart-ment of Radiology at the Georgetown University School of Medicine since 2005.

As part of his visiting professorships, Dr. Spies has lectured at numerous institutions in the USA and abroad, including Yale University, the University of Pennsylvania, the Vermont School of Medicine, the University of Texas Medical Center, the Taiyuan Central Hospital (China) and many more.

Prof. Spies has an active practice in uterine embolization for fibroids and has performed extensive research on the pro-cedure. He is recognised as an international authority on the treatment. He has published over 100 scientific studies, has given more than 250 invited presentations and has co-edited a text on uterine embolization. He continues to actively research uterine embolization and outcomes for various fibroid therapies.

Prof. Spies is a Fellow of the SIR and the ACR and has served on numerous national committees for both organisations. He currently serves as Secretary of the Society of Interventional Radiology. Among his many awards and honours are the Meritorious Service Award of the United States Air Force and the Distinguished Service Commission Award of the American College of Radiology. Prof. Spies has been voted one of Washington’s and one of America’s best doctors for seven years in a row.

Prof. Spies has been a reviewer for numerous journals, includ-ing the Journal of Vascular and Interventional Radiology, Human Reproduction, Obstetrics and Gynecology, the Journal of Women’s Health, the European Journal of Radiology and many more. For his work as reviewer, he received the Editor’s Award for Distinguished Editorial Board Service from the Journal of Vascular and Interventional Radiology and the Distinguished Reviewer Award from the Journal Obstetrics and Gynecology, both in 2009.

Prof. Spies is married to Vivian Fraga, a practicing obstetrician-gynaecologist, and has two children, Vivian and Ana Cristina. He enjoys travelling with his family and is an amateur land-scape photographer. He also enjoys woodworking and is an avid college basketball fan, particularly of the Georgetown Hoyas.

CIRSE Opening Ceremony and Awards James B. Spies will be awarded on

Saturday, September 1414:30-16:00

7Dignitaries

Peter Taylor was born in Bishop Auckland, County Durham, in the north of England. He was a chorister at Durham Cathedral and continued his schooling at Canterbury where he studied the piano under Ronald Smith. He was awarded a performers diploma as an Associate of the Royal College of Music. He stud-ied medicine at Emmanuel College, Cambridge (where he was also a choral exhibitioner) and at St. Thomas’ Hospital, London.

Peter trained as a vascular surgeon at St. Mary’s Hospital in Paddington under Averil Mansfield, John Wolfe and Andrew Nicolaides and was appointed to Guy’s and Lewisham Hospitals in 1991 and subsequently to Guy’s and St Thomas’ Hospital in 1997. In the early 1990’s Andy Adam was appointed Professor of Interventional Radiology at Guy’s Hospital and he encour-aged Peter’s close collaboration with John Reidy. This fruitful relationship introduced aortic endovascular procedures into the clinical repertoire locally. Notable collaborations with early endovascular pioneers included Claude Miahle, Fred Keller and Julio Palmaz which placed Guy’s at the forefront of aortic endovascular intervention in the UK.

Grants from the Charitable Foundation of Guy’s and St Thomas’ Hospital allowed the building of dedicated hybrid endovascu-lar interventional suites. Early work showed the effectiveness of endovascular thoracic intervention in preventing spinal cord ischaemia compared to open surgery.

Peter’s main interest continues to be in carotid and aortic in-tervention, particularly the endovascular treatment of aortic dissection. He took part in major randomised trials such as the UK Small Aneurysm Trial, the EVAR trials, the Asymptomatic Carotid Surgery Trial and the General Anaesthetic versus Local Anaesthetic trial for carotid endarterectomy. Recent work in-cludes the investigation of patients with aortic dissection by dynamic magnetic resonance imaging.

Peter has written many peer reviewed papers and book chap-ters. He has given numerous lectures at national and interna-tional meetings and is in demand as a key opinion leader in vascular intervention. He is co-chairman of the international Charing Cross Meeting held annually in London and is a regu-lar speaker at the Veith Symposium in New York. Together with John Reidy he organises the Guy’s Thoracic Masterclass which is an international meeting concentrating on cutting edge endovascular thoracic intervention. He is also a referee for nine major vascular journals.

Peter was awarded the James IV Travelling Scholarship in 1999 and visited Professor Safi at the Memorial Hermann Hospital in Houston, Professor Glovitski at the Mayo Clinic, Rochester, Minnesota, and Professors Jim May, John Harris and Geoff White in Sydney, Australia. He has been a visiting professor to the Houston Methodist Hospital and Baylor Medical School with Professor Alan Lumsden, the University of Pittsburgh Medical Centre with Professor Michel Makaroun and the Royal Prince Alfred Hospital in Sydney with Professor John Harris. Peter was president of the Vascular Society of Great Britain and Ireland in 2008-9. He became Clinical Professor of Vascular Surgery at King’s College London in 2010 and was made an honorary fellow of the British Society of Interventional Radiologists in 2010.

Peter lives with his wife Kok-tee, a retired radiologist, whom he met when they were both medical students in Cambridge. They have a mutual interest in the piano and classical music, regularly attending concerts and opera. They enjoy museums, art galleries and dining in fine restaurants in London and around the world.

Distinguished FellowPeter R. Taylor

CIRSE Opening Ceremony and Awards Peter R. Taylor will be awarded on


7

8

Distinguished FellowBien Soo Tan

Tan Bien Soo was born and raised in the island state of Singapore. He received his education at the Anglo-Chinese School, his father’s alma mater. Bien Soo then enrolled in medi-cal school at the National University of Singapore, graduating in 1985. He counts meeting and successfully courting his wife, Soo See, a fellow classmate, as his greatest achievement in medical school. Both of them then pursued postgraduate training in diagnostic radiology in Singapore, obtaining the Fellowship of the Royal College of Radiologists. When they married in 1989, they had visions of travelling the world together, attending radiological conferences. This did not quite materialise. Bien Soo pursued a career in Interventional Radiology while his wife, being the more sensible and capable half, developed her interests in ultrasound and breast imaging, in addition to caring for the couple’s children.

Bien Soo’s initial training in Interventional Radiology was in the Department of Diagnostic Radiology at the Singapore General Hospital (SGH), under the tutelage of Dr. Austin Htoo. He then had the privilege of pursuing a fellowship at Guy’s Hospital in London, where he trained under Prof. Andy Adam and Dr. John Reidy. He returned home in 1995, and soon after was appoint-ed Director of Vascular and Interventional Radiology in SGH. His tenure witnessed rapid expansion of the Interventional Radiology services in SGH, establishing the centre as the largest in South East Asia.

Having greatly benefited from his training at Guy’s Hospital, Bien Soo established a clinical fellowship in Interventional Radiology at SGH, with the objective of equipping radiologists in the region with basic and advanced skills in Interventional Radiology. This ‘hands-on’ fellowship programme has since flourished and currently 4-6 fellows from across Asia and beyond are trained annually at SGH.

Bien Soo was the inaugural Chairman of the Cardiovascular and Interventional Radiology Section of the Singapore Radiological Society from 2000 to 2002. Having trained in Europe, he has been a corresponding member of CIRSE since 1996. He was conferred CIRSE fellowship in the year 2000. He is also a cor-responding fellow of SIR. Bien Soo has lectured widely on Interventional Radiology in the Asia Pacific region, as well as at the annual CIRSE and SIR meetings. In 2011, he joined the team of editors at CVIR. He is currently the President-Elect of the Asia Pacific Society of Cardiovascular and Interventional Radiology and the organising chairman of the Asia Pacific Conference of Cardiovascular and Interventional Radiology 2014, which will be held in Singapore. Bien Soo was appointed Head of the

Department of Diagnostic Radiology in SGH in 2002, a post he took over from one of his mentors, Dr. Tan Kim Ping, and which he held until 2010. He was also the President of the Singapore College of Radiologists from 2009 to 2011.

Bien Soo’s passion for teaching extends beyond Interventional Radiology. He is also deeply involved in undergraduate and post-graduate training for diagnostic radiology. He has chaired the national committee for postgraduate diagnostic radiology train -ing in Singapore since 2008. In addition, he is an Associate Pro -fessor in both medical schools in Singapore (the Yong Loo Lin School of Medicine and the Duke-NUS Graduate Medical School).

Bien Soo’s involvement in research is based on his conviction that interventional radiologists should play a critical role in shaping the evidence in the field of minimally invasive therapy. The team at the Interventional Radiology Centre at SGH has conducted several investigator-led randomised controlled trials, studying various aspects of haemodialysis interventions and critical limb ischaemia therapy.

Beyond the arena of radiology, he has held various appointments in the Singapore Armed Forces, by virtue of the compul sory national service programme in Singapore. He was the Commanding Officer of a medical support battalion from 1999 to 2003, an out -standing unit that won the Best Combat Service Support Batta-lion Award for a record-breaking nine years from 1996 to 2004.

Bien Soo and Soo See are the proud parents of four wacky child-ren, Sarah, Deborah, Joanna and Yuancheng, and they have an even wackier dog called Cleo. They treasure family time toge-ther and love travelling when the opportunity arises. Since his knees gave way last year, Bien Soo has had to give up running, and he now enjoys a good swim. He has been a long-suffering fan of Manchester City Football Club since 1969, and views the club’s new found wealth and success with some suspicion. He also enjoys discovering new food haunts on the island of Singapore, where eating is a favourite past-time, and aspires to start a food blog when he retires.

CIRSE Opening Ceremony and Awards Bien Soo Tan will be awarded on


8 Dignitaries

9Dignitaries

Gold MedallistJosé I. Bilbao

José Ignacio “Nacho” Bilbao was born in 1956 in Bilbao and grew up in the Cantabria region. He studied medicine at the Univer-si ty of Navarra (1973-1979) where he received his doctorate cum laude in 1988. Following his specialisation in ra diology at the Uni versity Clinic of Navarra (CUN), he worked in the hospi-tal’s Ra dio logy Department. In 1991, José Ignacio Bilbao was made Asso ciate Professor of Radiology and Physical Medi cine at the University of Navarra, and became a Professor in 2007. From 1998 until 2004, Prof. Bilbao directed the Radiology Department of the CUN.

From the beginning of his studies, Prof. Bilbao showed great interest in the surgical specialties. During a 1982 fellowship at the MD Anderson in Houston, Texas, under the tutorship of Dr. Sydney Wallace and Dr. Luis Alonso de Santos, Prof. Bilbao discovered the great therapeutic potential of angiographic pro cedures, needles and drainages. With the valuable help of other specialists of the CUN and after various visits to hospitals across Spain with Dr. Ricardo Tobio and Dr. Manuel Maynar, among others, Prof. Bilbao co-established the CUN’s Inter-ventional Radiology Department, which he has headed ever since.

In 1984, the department started using intra-arterial chemothe-rapy in the treatment of bone tumours and hepatic tumours, as well as breast and lung neoplasms. After visiting the Univer-sities of Chiva (Dr. Kunio Okuda) and Nara (Dr. Hideo Uchida) with his colleagues, Prof. Bilbao started using lipiodol and thus chemoembolization for the treatment of hepatocellular carcinomas in 1986. Upon meeting Dr. Francis Joffre and Dr. Hervé Rousseau in 1989, Prof. Bilbao began collaborating with the renowned experts on various subjects, including TIPS. After carrying out a comprehensive experimental study, the team started performing exclusive transjugular access, echo-graphic guidance of portal puncture and the use of autoex-pandable endoprostheses. Prof. Bilbao later worked with Joffre and Rousseau on a study showing the superiority of covered vs. non-covered prostheses in terms of permeability. During that time, the team also collaborated with Drs Chigogidze and Avaliani from the Bakuolev Institute in Moscow on experimen-tal models for extrahepatic porto-cava connections by means of magnets and specific metal prostheses. In co-operation with the Department of Animal Histology of the Veterinarian Faculty of the University of Zaragoza, Prof. Bilbao started studying the “in vivo” characteristics of various embolizing agents in 2002, the results of which have provided more insight into the differ-ences in their characteristics and applicability. In 2003, the IR department also began using radioembolization.

Prof. Bilbao has authored 35 book chapters and co-edited a book on radioembolization together with Dr. Reiser. Further-more, he has published 155 articles in Spanish and interna-tional peer-reviewed journals, achieving an impact factor of 200 and approximately 1,000 citations. Prof. Bilbao edits and reviews for 10 Spanish and international journals, including JVIR, for which he is associate editor. He has presented 400 pa-pers at various congresses and has been invited to give 300 lectures at conferences around the globe.

In 1986, Prof. Bilbao co-founded the Spanish Society of Vascular and Interventional Radiology (SERVEI) which he headed from 1992 until 1995. He has been an active member of CIRSE since its beginnings and has attended every one of its congresses, presenting original material through posters, oral presentations (awarded in 2001, 2002 and 2004) or in-vited lectures. Prof. Bilbao has been very active in other areas of CIRSE, serving as a member of the Clinical Practice Guide Task Force (1999-2001), as Education Officer (2001-2003), Local Host Committee Co-Chairman (2004, 2010) and Member of the Executive Board upon invitation (2006-2009). In 2010 he was the Josef Roesch Lecturer for CIRSE, speaking on TIPS. The same year he was awarded the CVIR Editor’s Medal.

Prof. Bilbao is currently President of the European Congress of Radiology (ECR 2013). Within the European Society of Radiology (ESR), he has served as a member of the Educational Board (2002-2008) and has very actively contributed to the ESR’s e-learning initiatives. He is the Spanish representative in the POC-UEMS (2002-2005) and the chairman of the ESR’s Subspe-cialty Committee (2005-2008). He actively contributed to the creation of the ESR, for which he received the Diploma of the European Association of Radiology in 2007. Prof. Bilbao’s most outstanding awards have been conferred by the RSNA for his work on TIPS (1992-1998) as well as by the Dr. J.M. Sánchez Pérez Foundation and the Rafael Hervada Foundation for his work on direct vascular connections in 2003.

At a national level, Prof. Bilbao has served as the delegate for international affairs of the Spanish Society of Medical Radiolo gy (SERAM) from 2002-2006. Today, he serves as one of the society’s representatives in the National Commission on Radiodiagnostics.

CIRSE Opening Ceremony and AwardsJosé I. Bilbao will be awarded on


Andrew Holden was born in Auckland, New Zealand, on August 22, 1960. He was raised in Wellington as one of seven children, with three older sisters, two younger sisters and one brother. Although Andrew did well at school, his real passion was sport as he represented his school in top rugby and cricket teams. He was also a national prize winner in public speaking and debating.

Andrew decided to study medicine at Otago University in Dunedin – the oldest and most renowned medical school in New Zealand. After completing his clinical years as a medical student in Wellington and taking a 12-month break from medi-cine to travel, Andrew was accepted into the 5-year radiology training programme at Auckland Hospital. In his final year, he was appointed chief registrar and won the best research paper prize for a junior radiologist or registrar at the 1992 RANZCR Annual Scientific Meeting in Queensland, Australia. The prize was a week with Professors Ken Thomson and Arina Van Breda (then president of SIR) doing intervention at the Royal Melbourne Hospital. This experience confirmed to Andrew that Interventional Radiology was his career pathway.

In 1994, Andrew travelled to Royal Perth Hospital in Australia to gain two years of fellowship experience in Interventional Radiology and body imaging. During that time, the Vascular Surgery and Interventional Radiology Departments worked closely to develop an endograft for aneurysm disease which subsequently became the highly successful Cook Zenith en-dograft. Andrew was lucky enough to be an integral part of the team during the first 100 human cases in Perth and was involved in proctoring other national and international sites as they used the device.

In 1997, Andrew returned to Auckland Hospital as a staff inter-ventional radiologist and in 2002 he was appointed Director of Interventional Radiology, a position he still holds today. He is head radiologist for the NZ Liver Transplant Programme and co-director of the Auckland Endovascular Service. In 2005, he was appointed associate professor of radiology at Auckland University. Andrew is a committee member of IRSA (Interven-tional Society of Australasia) and ARGANZ (Abdominal Radio-logy Society of Australia and New Zealand) as well as an ex-aminer for the RANZCR. He is a member of CIRSE and national representative for ESGAR.

Andrew has always had an interest in research, particularly re-lated to interventional devices and techniques. He is the au thor of over 60 articles in peer-reviewed journals and five book chapters. His interests include advanced endovascular aneu-rysm repair techniques, renal and carotid artery interven tion, intervention in critical limb ischaemia and advanced liver imag-ing. Together with his vascular surgical colleague and medi-cal school classmate Andrew Hill, Andrew runs the Vascular Research Programme at Auckland Hospital, employing 3 full-time research coordinators. Andrew has been the principal investigator in 25 “first-in-man” device trials.

Andrew has presented many times at international scientific meetings, often as part of the invited faculty. He has per-formed over 50 live interventional cases broadcasts from Auckland Hospital to overseas sites such as Germany, France, Hong Kong, USA and Australia. He has proctored interven-tional cases in China, India, Thailand, Hong Kong, Malaysia and Australia.

Andrew has been married to his best friend Tracey for 28 years, getting married when he was 24 and she was only 22. They met at the university hostel in Dunedin, shared a flat the fol-lowing year when still “just good friends” and then fell in love the following year. They have four fantastic children. Sam (26) is a successful international criminal lawyer, having worked in The Hague and now in London. He is also a musician, gaining great success in “The Voice” in Holland in 2012. Tom (22) is in his fourth year of architecture and is also a talented musician, Jacob (18) is in his first year of engineering and Grace (13) is in her first year of secondary school.

Andrew likes to stay fit, loves hiking, climbing and has run six marathons, the most recent in 2012. He plays golf and tennis and loves both river and sea fishing. Andrew is very patriotic and immensely proud of being a Kiwi. He loves his beautiful country, family and friends.

Gruentzig LecturerAndrew Holden

Andreas Gruentzig LectureEVAR for AAA – evolution or revolution?

Sunday, September 1514:30-15:00

10 Dignitaries

11Dignitaries

A native of Rome, Italy, Prof. Mario Bezzi attended the Universi ty of Rome “Sapienza”, where he graduated summa cum laude from the School of Medicine in 1982. He entered the Depart-ment of Surgery of the same university and practiced surgery for one year; this post-graduate training in surgery was instru-mental in improving his clinical background and surgical skills. While involved in the first clinical applications of intraoperative ultrasound, however, he developed an interest in diagnostic imaging.

Between 1983 and 1986, he completed his residency in diag-nostic radiology at the University of Rome “Sapienza”, followed by a two-year fellowship in CT-US-MRI at the Department of Radiology of Thomas Jefferson University and at the University of Pennsylvania, both in Philadelphia, under the tutorship of Dr. Barry B. Goldberg and Dr. Herbert Y. Kressel.

In 1988, he started his interventional career in the Division of Cardiovascular and Interventional Radiology at the Hospital of the University of Rome. His mentor at that time was Prof. Plinio Rossi. Many of the procedures in non-vascular radiology which are now considered routine, such as abscess drainage, biliary drainage and stenting, dilation of benign biliary stric-tures, chemoembolization and RF ablation of liver tumours, were either introduced to Italy or further developed by the team of interventional radiologists working in this division.

Prof. Bezzi is Aggregate Professor of Radiology at the University of Rome “Sapienza” and is responsible for the management of human and technological resources in his department. He is an enthusiastic teacher and is committed to training the next generation of radiologists, tutoring both medical students and residents in imaging and Interventional Radiology.

His clinical practice consists mainly of image-guided therapy in oncology and his research interests focus primarily on liver tumours. He has been involved in a number of grant-funded studies, often as principal investigator. Currently his interest is centred in MR-guided focused ultrasound, and he is involved in two European projects on the applications of MRgFUS in moving organs.

Prof. Bezzi has authored 15 book chapters and edited a book on biliary tract radiology in collaboration with Prof. Plinio Rossi. Furthermore, he has published 150 articles in Italian and inter-national peer-reviewed journals, achieving approximately 1,200 citations. Prof. Bezzi reviews for a number of internation-al journals (CVIR, JVIR, European Radiology) and has presented more than 400 papers at various congresses.

From early in his career, Prof. Bezzi has been involved in the activities of CIRSE. He was nominated Chairman of the Scientific Programme Committee for the 1996 Annual Meeting in Madeira, and subsequently supervised the Scientific Pro gramme of CIRSE ‘97, ’98 and ‘99. Since then, Prof. Bezzi has been very ac-tive within the CIRSE, serving as Chairman of the Standards of Practice Committee (1999-2003), as organiser of CIRSE 2006 in Rome, as a member of the Programme Committee (2007-2012), and as a member of the Executive Committee since 2012.

Currently, he is Editor-in-Chief of ESIRonline, the website platform that houses all lectures and presentations from CIRSE events.

Mario Bezzi has been married to his charming wife, Ada, for more than 25 years and is the proud father of a beautiful daughter, Costanza. In his free time, he enjoys watersports and sailing, as well as travelling and contemporary art. He is also a wine-lover who enjoys wine tastings and visiting vineyards.

Roesch LecturerMario Bezzi

Josef Roesch LectureHigh-intensity focused ultrasound: an IR tool for the future?Tuesday, September 1713:00-13:30

12 The Wave of Innovation

C RSE

Preliminary Faculty

Preliminary Facultyas per printing date – subject to change

Abdel Rehim M. Clichy-Paris/FRAbi-Jaoudeh N. Bethesda, MD/USÅkesson M. Malmoe/SEAkhan O. Ankara/TRAlexopoulou E.* Athens/GR Alfke H.* Lüdenscheid/DEAl-Kutoubi A.M. Beirut/LBAlmeida P.A.M.S. Viseu/PTAmoretti N. Nice/FRAndersen P.E.* Odense/DK Andersson T. Stockholm/SEAnselmetti G.C. Turin/ITArai Y. Tokyo/JPAtar E. Petah Tikva/ILBaek J.H. Seoul/KRBale R. Innsbruck/ATBarnacle A.M. London/UKBarranco Pons R. Barcelona/ESBartal G. Kfar-Saba/ILBasile A.* Catania/ITBatistaki C. Athens/GRBelli A.-M.* London/UK Bérczi V.* Budapest/HU Beregi J.-P. Nîmes/FRBerkefeld J. Frankfurt/DEBerlis A. Augsburg/DEBezzi M.* Rome/IT Bianchi Cardona L. Barcelona/ESBilbao J.I.* Pamplona/ES Binkert C.A.* Winterthur/CHBoyer L.* Clermont-Ferrand/FRBoyvat F.* Ankara/TRBreen D.J. Southampton/UKBrennan P. Dublin/IEBrountzos E.* Athens/GR Buecker A.* Homburg/DE Burnes J.P. Clayton, VIC/AUBuy X. Bordeaux/FR Cahill A.M. Philadelphia, PA/US Carnevale F.C. São Paulo/BR Carrafiello G.* Varese/IT Castaño C. Badalona Barcelona/ES Černá M.* Olomouc/CZ Chapot R. Essen/DE Chatziioannou A.N.* Athens/GR Chavan A. Oldenburg/DE Ciaralli C. Rome/IT Clark T.W.I. Philadelphia, PA/US Clark W.A. Kogarah, NSW/AU Clifton A. London/UK Cognard C. Toulouse/FR

Corona M. Rome/IT Crocetti L.* Pisa/IT Dake M.D. Stanford, CA/US Darcy M. St. Louis, MO/US Das M. Maastricht/NL de Baère T.* Villejuif/FR de Haan M.W.* Maastricht/NL De Vries C. Bloemfontein/ZA Defreyne L. Ghent/BE Denys A.* Lausanne/CH Di Primio M. Paris/FR Do Y.-S. Seoul/KR Düx M.* Frankfurt/DE Ellis P.K.* Belfast/UKEngland A. Liverpool/UK Fanelli F.* Rome/IT Filippiadis D.K. Athens/GR Fournier-Dujardin L.S. Paris/FR Funaki B.S. Chicago, IL/US Funovics M.A.* Vienna/AT Fuster Obregón J. Barcelona/ES Fütterer J.J. Nijmegen/NL Gaines P.A. Sheffield/UK Gandini R. Rome/IT Gangi A.* Strasbourg/FR García-Pagán J.C. Barcelona/ES Garnon J. Strasbourg/FR Gebauer B. Berlin/DE Gedroyc W.M. London/UK Geschwind J.-F.H. Baltimore, MD/US Gillams A.* London/UK Giménez M.E. Buenos Aires/AR Given M.F. Dublin/IE Glynos M.K. Athens/GR Goffette P.P.* Brussels/BE Gogna A. Singapore/SG Goh G.S.* London/UK Golzarian J. Minneapolis, MN/US González García A. Sevilla/ES Grosso M. Cuneo/IT Guerini H. Paris/FRGuimaraes M. Charleston, SC/US Güven K. İstanbul/TR Haage P.* Wuppertal/DE Hacking N. Southampton/UK Hamady M.S. London/UK Hardman J. Bath/UK Haskal Z.J. Baltimore, MD/US Haslam P.J.* Newcastle-upon-Tyne/UK Hatzidakis A.* Iraklion/GR Hausegger K.A.* Klagenfurt/AT

Barcelona 2013 13Preliminary Faculty

* EBIR Diploma holders EB I R European Board of Interventional RadiologyThe European qualification in Interventional Radiology

Hechelhammer L.* St. Gallen/CH Helmberger T.K.* Munich/DEHenkes H. Stuttgart/DE Hicks M.E. Houston, TX/US Hinchliffe R.J. London/UK Hirota S. Nishinomiya/JP Hoffmann R.-T. Dresden/DE Hohl C.* Siegburg/DE Holden A. Auckland/NZ Huppert P.E. Darmstadt/DE Iezzi R. Rome/IT Irani F.G. Singapore/SG Itkin M. Philadelphia, PA/US Jackson J.E.* London/UKJahnke T.* Neumünster/DE Jakobs T.F. Munich/DE Jargiello T. Lublin/PL Jaschke W.* Innsbruck/AT Karani J.B. London/UK Karnabatidis D.* Patras/GR Katoh M. Krefeld/DE Katsanos K.N.* London/UKKaufman J.A. Portland, OR/US Keeling A. Dublin/IE Kelekis A.D.* Athens/GR Kenny L.M. Brisbane, QLD/AU Kessel D.O.* Leeds/UK Kettenbach J.* Bern/CH Kichikawa K. Nara/JP Kim Y.H. Daegu/KR Kobeiter H. Créteil/FR Köcher M.* Olomouc/CZKoelemaij M.J.W. Amsterdam/NL Krajina A.* Hradec Králové/CZKroencke T.J.* Berlin/DEKrokidis M.* London/UK Kuang M. Guangzhou/CN Lammer J.* Vienna/AT Lawler L.P.* Dublin/IELee M.J.* Dublin/IE Lencioni R.* Pisa/IT Liebig T. Köln/DE Loffroy R. Dijon/FR Loftus I. London/UK Lohle P.N.M. Tilburg/NL Lönn L.* Copenhagen/DK

López-Ben S. Girona/ES Lozano J.M. Bogota/CO Lyon S.M. Melbourne, VIC/AU Macdonald S.* Newcastle-upon-Tyne/UK Machan L. Vancouver, BC/CA Madureira A.M. Porto/PT Mahnken A.H.* Marburg/DE Malagari K.* Athens/GRMaleux G.A.* Leuven/BE Manca A. Candiolo/IT Manzi M. Abano Terme/IT Markus H.S. London/UK Martin D.F. Manchester/UK Martínez de la Cuesta A. Pamplona/ES Masala S. Rome/IT Maskova J.* Aberdeen/UK Matson M.B. London/UK Matzko M. Dachau/DE McBride K.D. Dunfermline/UK McEniff N.* Dublin/IEMcPherson S.J.* Leeds/UK McWilliams R.G.* Liverpool/UK Melchiorre F. Milan/IT Melzer A. Dundee/UK Minko P. Homburg/DE Monfardini L. Milan/IT Mueller P.R. Boston, MA/US Müller-Hülsbeck S.* Flensburg/DE Munneke G.J. London/UK Napoli A. Rome/IT Narayanan G. Miami, FL/US Nicholson A.A.* Leeds/UK Nutting C.W. Englewood, CO/US Oguzkurt L.* Adana/TROrsi F.* Milan/ITPalussière J. Bordeaux/FR Panci S. Florence/IT Park S. Daejeon/KR Paulo G.N. Coimbra/PT Peetrons P. Brussels/BE Pelage J.-P. Caen/FR Pellerin O. Paris/FR Peregrin J.H.* Prague/CZPereira P.L.* Heilbronn/DE Peynircioglu B. Ankara/TR Pfammatter T.* Zurich/CH


* EBIR Diploma holders EB I R European Board of Interventional RadiologyThe European qualification in Interventional Radiology

14 Preliminary Faculty

Piotin M. Paris/FR Pisco J.M. Lisbon/PT Platts A.D. London/UK Pozzi-Mucelli F. Trieste/IT Preckel B. Amsterdam/NL Pua U. Singapore/SG Pulido-Duque J.M. Las Palmas de Gran Canaria/ES Punamiya S. Singapore/SG Qanadli S.D. Lausanne/CH Rand T.* Vienna/ATRay, C.E. Golden, CO/US Reekers J.A.* Amsterdam/NLReimer P.* Karlsruhe/DE Richter G.M.* Stuttgart/DE Rilling W.S. Milwaukee, WI/US Roberts A.C. La Jolla, CA/US Robertson I.* Glasgow/UK Roček M.* Prague/CZ Rodière M. Grenoble/FR Rose S.C. San Diego, CA/US Rosen G. Tel Aviv/IL Rousseau H. Toulouse/FR Ruffino M.A. Turin/IT Ryan A.G. Waterford City/IE Ryan M.* Dublin/IESabharwal T.* London/UK Sala Blanch X. Barcelona/ES Salem R. Chicago, IL/US Sapoval M.R.* Paris/FRSchoder M.* Vienna/AT Schultze Kool L.J.* Nijmegen/NL Schürmann K.* Dortmund/DESharma S. Delhi/IN Shoenfeld R.B. West Orange, NJ/US Sibert A. Clichy/FR Sierre S. Buenos Aires/AR Silkoset R.D. Østerås/NO Solbiati L. Busto Arsizio/IT Song H.-Y. Seoul/KR Soulez G. Montreal, QC/CA Spies J.B. Washington, DC/US Stracke C.P. Bonn/DE Szczerbo-Trojanowska M. Lublin/PL

Tacke J.* Passau/DE Tan B.S. Singapore/SG Tay K.-H. Singapore/SGTaylor P.R. London/UK Tepe G.* Rosenheim/DE Tesdal I.K.* Friedrichshafen/DE Thiounn N. Paris/FR Thompson M. London/UK Thony F. Grenoble/FR Trerotola S.O. Philadelphia, PA/US Tsetis D.K.* Iraklion/GR Tsoumakidou G. Strasbourg/FR Turmel-Rodrigues L.* Tours/FR Tutton S.M. Milwaukee, WI/US Uberoi R.* Oxford/UK Urbano J. Madrid/ES Válek V.* Brno/CZ van Delden O.M.* Amsterdam/NL van den Berg J.C. Lugano/CH van den Bosch M. Utrecht/NL van Erkel A.R. Leiden/NL van Lienden K.P. Amsterdam/NL van Overhagen H.* The Hague/NL van Rijswijk C.S.P. Leiden/NL van Strijen M.J.L. Nieuwegein/NL Vano E. Madrid/ES Vari A. Rome/IT Veltri A. Orbassano/IT Verhoeven E.L. Nuremberg/DE Vilar J. Valencia/ES Vorwerk D.* Ingolstadt/DE Vos J.A. Nieuwegein/NL Vrachliotis T.-E.G.* Athens/GR Wagner H.-J.* Berlin/DE Waldenberger P.* Linz/AT Walser E.M. Galveston, TX/US Watkinson A.F.* Exeter/UK West D.J.* Stoke-on-Trent/UKWidmark A. Østerås/NO Wilhelm K.E.* Bonn/DE Wolf F.* Vienna/ATWood B.J. Bethesda, MD/US

Barcelona 2013 CIRSE meets ... 15


The CardioVascular and Interventional Radiology (CVIR) Subsection of the Singapore Radiological Society (SRS) was formed in the year 2000 and currently comprises just over 40 members. Most of our members have undergone IR fellow-ship training in the UK, Australia, USA, Canada and more recently in France, Italy and Germany. Our public and private hospitals have state-of-the-art angiographic equipment and are offering the full spectrum of IR services.

Our subsection members meet monthly to share interesting cases or mortality/morbidity cases, providing an excellent chance to learn from each other. We also regularly invite over-seas experts to lecture at our monthly meetings. The highlight of our education calendar is the annual workshop – WIRES (Workshop in Interventional Radiology Education Singapore). The workshop is conducted over a weekend with local and overseas experts sharing their expertise on one or two IR themes. Concurrent sessions designed for IR nurses and technicians are also included in the WIRES programme.

We look forward to a closer collaboration with CIRSE, particularly in the areas of IR education, research and best practices!

Kiang-Hiong TayChairman, CVIR Subsection of the SRS

CIRSE meets ...Singapore

Tuesday, September 17, 10:00-11:00CM 2605 CIRSE meets Singapore

Moderators: M.J. Lee (Dublin/IE), K.-H. Tay (Singapore/SG)

2605.1 IR management of ultra-large hepatocellular carcinomas

U. Pua (Singapore/SG)

2605.2 Haemodialysis access interventions – randomised trials from Singapore

F.G. Irani (Singapore/SG)

2605.3 “Angioplasty first” approach to critical limb ischaemia

A. Gogna (Singapore/SG)

The CIRSE meets… programme has proved to be an important platform for establishing and strengthening the relations between CIRSE and its distinguished Group Members – the national societies in the field of Interventional Radiology. Experts from various regions around the world have provided interesting insights into the current status of Interventional Radiology as well as the state of specific procedures and conditions in their home countries.

C RSE

The programme is designed to facilitate itinerary planning allowing delegates to follow one of these themes with little or no overlap. In this booklet you will find colour codes for each of the six main themes. Those codes can be found throughout the whole programme (programme overview, main theme description, programme in chronological order). This way you will easily recognise your topics of interest.

How to navigate the scientific programme in this booklet

VASCuLAR INTERVENTIONS

The programme for vascular interventions will once again be one of the most dominant in the 2013 congress, with numerous Special Sessions devoted to vascular disease. Among the high-lights of the CIRSE 2012 congress in Lisbon were the out comes of the latest trials in the management of SFA and BTK peripheral vascular disease, and these sessions will be repeated under the new umbrella of Evidence Forums. This new format will be devoted to trial updates and is a continuation of the in creased emphasis on evidence in the CIRSE scientific programme.Special Sessions will also give updates on the management of abdominal and thoracic aortic disease, renal denervation, hepatic, portal and mesenteric thrombosis and upper extre mi ty peripheral vascular disease. As venous disease is becoming an increasing part of the workload of interventional radiologists, there will be Special Sessions on varicose veins, thrombolysis of deep venous thrombosis and haemodialysis. The Controversies Sessions involving debates continue to be popular, and this year’s sessions will be on the management of aortic disease, endoleaks, peripheral vascular intervention and portal hyper-tension. Delegates wishing to learn in an informal atmosphere by working up cases with experts are encouraged to attend the Workshops and Interactive Case Sessions, which will focus on important aspects of vascular interventions, such as varicose veins, lower extremity occlusive disease, endoleak manage-ment and the management of chylothorax. There will be a new Hands-on Workshop devoted to renal de nervation, which will involve the range of new devices available for this exciting procedure. The Hands-on Workshop on Closure Devices is still enjoying great popularity and will again be part of the CIRSE programme in 2013, with the added feature of including percutaneous large vessel closure devices for endovascular aortic procedures.

INTERVENTIONAL ONCOLOGy

Interventional oncology will occupy a deservedly prominent place in the CIRSE 2013 programme, with the aim of illustrating new advances in the field. The Scientific Programme Committee has endeavoured to create exciting sessions, featuring updates on oncological interventions that will be essential viewing for experts, as well as sessions that will appeal to IRs who want to become more involved in interventional oncology. This year, one of the Hot Topic Symposia – an integral feature of the CIRSE programme – will be devoted to the role of interventio-nal oncology in lung cancer. A high-level international faculty will discuss the new developments in this field and how inter-ventional oncologists can play a role in the management of lung cancer. In the Special Sessions programme, there will be two Evidence Forum sessions on the management of hepato-cellular carcinoma and colorectal metastases. The aim of these sessions will be to review the outcomes of the major trials of all competing therapies for these diseases, with a summarising conclusion given by the moderator of each session, whose role it will be to provide recommendations regarding the best treatment methods based on the available evidence. Other high-lights of the Special Sessions will be high intensity focused ultrasound (HIFU), irreversible electroporation and new plat forms for drug delivery in interventional oncology. Furthermore, there will be Special Sessions on renal tumour ablation and new cli nical applications for interventional oncologists. Ablation tech niques for different types of cancer will also be discussed in the onco-logy Workshops and Hands-on Work shops, where the particu-larly popular sessions “Starting your practice” and “Liver” will again take place twice, in order to give more delegates the opportunity to attend. Participants will be able to access the full range of ablation systems (RFA, cryo therapy, microwave, electroporation). Increased focus will be given to ultrasound-guided procedures in a “How I do it” format. Highlights will include radioembolization and portal vein embolization.

16 Main Themes The Wave of Innovation

Main Themes

NON-VASCuLAR INTERVENTIONS

This year, the programme committee has composed three Foundation Course sessions, three Special Sessions, five Workshops, and two Interactive Case Sessions in the non- vascular field. Foundation Course sessions are aimed at trainee IRs and IRs who wish to broaden their practice into new areas. The Foundation Course topics in 2013 will be spine interven-tions, biliary interventions and biopsy and abscess drainage, all in a “How I do it” format. Besides Special Sessions on the role of non-vascular IR in gastrointestinal and genito-urinary inter vention, there will be a session on “New horizons in musculoskelet al interventions”, which will include lectures on percutaneous screw fixation of fractures and MR-guided interventions. Peri pheral bone interventions, MSK ultrasound-guided procedures and acute pancreatitis will be among the Workshop topics for CIRSE 2013. The CIRSE 2012 Hands-on Workshops on “Vertebral augmentation techniques” proved, as ever, to be a great success and will again be held in 2013. Three sessions will be offer ed in which participants will have the opportunity to practice needle placement, cement preparation and injection.

NEuRO INTERVENTIONS

After attracting major interest from CIRSE delegates in 2011, the neuro interventions track experienced a significant increase in session attendance in Lisbon in 2012, with most rooms filled to capacity. More and more vascular interventional radiologists in Europe are becoming involved in neuro interventions, parti-cu larly in the management of acute stroke. With this in mind, the neuro programme for 2013 has been expanded and will include two Foundation Course sessions, two Special Sessions, three Workshops and a Hot Topic Symposium. We envisage that the Hot Topic Symposium on the role of interventional radiologists in the management of acute stroke will be one of the 2013 congress highlights. Senior interventional radiologists and senior neuroradiologists will discuss several important aspects of this topic. The two new Foundation Course sessions, aimed at interventional radiologists who wish to become more involved in stroke therapy, will contain lectures that will discuss all relevant aspects of stroke therapy for interested IRs. Special Session and Workshop topics will include carotid and vertebral intervention, fundamentals of intracerebral aneurysms and vascular malfor mation management, and the management of epistaxis. There will be two Hands-on Workshops on stroke therapy. Partici pants will have the opportunity to test several devices specifically de signed for intracranial thrombectomy in a simulator or flow model under the supervision of well- recognised experts in this field.

IR MANAGEMENT

CIRSE encourages interventional radiologists to become in -volved in IR management, as clinical care is an important as-pect of practice in Interventional Radiology. The introduction of IR man agement at CIRSE 2011 was a great success and it con-tinued to be popular at CIRSE 2012. Accordingly, the IR manage -ment programme has been expanded for the CIRSE 2013 pro-gramme. Besides a Special Session focusing on radiation dose management and anaesthesia, sedation and analgesia, there will be an exciting session on training and accreditation for IRs. This session will discuss the new CIRSE IR curriculum, the role of the EBIR and other issues, such as the pros and cons of re-certification. Furthermore, a Special Session will be dedicated to clinical practice for IRs in the management of lower limb occlu sive disease. This session will explore how IRs can provide total man agement of the patient with lower limb arterial dis-ease. In the Workshop programme, there will be a Workshop entitled “How to pass the EBIR”. Aspects of IR management will not only be dealt with in sessions specifically labelled as “IR Management” topics. Issues such as patient referral, the relationship with other clinical services and the management and follow-up of patients will be addressed in many sessions, producing a common pathway throughout the whole session programme.

Barcelona 2013 17


Transcatheter embolization, now an integral part of the daily practice of most interventional radiologists, will continue to be represented by an extensive educational programme at CIRSE 2013. There will be three Foundation Course sessions devoted to embolization, focusing on gastrointestinal haemorrhage, fe-male genito-urinary embolization and vascular malformations. All Foundation Course lectures will be delivered in a “How I do it” format, and are aimed at trainees in IR or newly qualified IRs.As usual, there will also be a comprehensive programme of Spe cial Sessions and Workshops which will cover all facets of embo li za-tion therapy. The main Special Session topics will be uterine artery embolization, embolization in the thorax, visceral artery aneurysms, trauma and an exciting session entitled “Prostate artery embolization: real benefit or myth?”. Delegates are also encouraged to attend the Interactive Case Session on haemor-rhage, which will provide the opportunity to learn in a more in formal and interactive atmosphere. There will be a series of embolotherapy Workshops and all will involve case-based dis-cussions to illustrate the topics. The “Embolization: materials and tools” Hands-on Workshop has become one of the highlights of the practical programme at CIRSE, giving participants insight in to the manipulation of the available embolization tools and mate-rials, such as liquid and particulate agents, glue, coils and plugs.

TRANSCATHETER EMBOLIzATION

The Wave of Innovation18 Session Types

CIRSE Session Types

Amazing InterventionsThe aim of this new session is to present examples of unusual and difficult interventional procedures. Acclaimed experts in interventional radiology will present brief cases of their most un -usual and challenging procedures. The emphasis of the session will be to highlight innovative ways that interventional radiolo-gists can solve difficult problems and get out of trouble. It is en - visaged that the session will be both educational and entertaining.

“CIRSE meets …” SessionThe “CIRSE meets …“ programme proved to be an important platform for establishing and strengthening the relations between CIRSE and its distinguished Group Members – the National Societies in the field of Interventional Radiology.For the detailed programme, please refer to page 15.

Evidence ForumsEvidence Forums are a new type of Special Session focusing on the outcomes of major trials investigating devices or techniques for conditions commonly treated by interventional radiologists. Each forum will consist of several short talks presented by leaders in the field. Each speaker will present the evidence for and against the use of a specific device or technique for the treatment of the disease under evaluation. At the end of the session, the modera tor will summarize the evidence presented and provide conclusions regarding the best method of treatment based on the current evidence.

Film Interpretation QuizThe Film Interpretation Quiz is one of CIRSE’s most popular sessions and will be run as a “last man standing” quiz. The Quiz Master will present the audience with two possible answers to each case – those choosing incorrectly will be eliminated and must sit down, while those who get the answer right will con-tinue to the next case. The last few contestants left standing will be invited onstage for a head-to-head finale.

Foundation CoursesFoundation Courses cover a specific area of Interventional Radiology, focusing on basic principles and illustrating the procedure in a step-by-step fashion. They are designed for radiologists in training and new consultants, as well as for experienced consultants who require a refresher course on the subject. There will be plenty of time for questions and discussion. Each session will last one hour.For the detailed programme, please refer to pages 22-23.

Free Paper SessionsResearchers will present original papers on new and original aspects of Cardiovascular and Interventional Radiology. Select ed papers will be gathered into sessions, each dealing with a homogenous topic. There will be time for discussion between researchers and attendees after each presentation.Featured Papers:In order to achieve a more interactive format to the Free Paper sessions, one paper per session will be highlighted. More time

will be dedicated to this featured paper by means of further que stions prepared prior to the meeting by the moderator. This will ensure a more structured and thorough discussion of the topic.

Hands-on WorkshopsThe participants of Hands-on Workshops can follow live demon-strations of interventional techniques and practice certain pro-cedures under the guidance of a technician and/or instructor.For the detailed programme, please refer to pages 46-51.

Hot Topic SymposiaThe Hot Topic Symposia aim to address important IR topics that are current and controversial in the setting of a plenary session. Invi ted speakers will give brief lectures on important aspects of the subject under discussion. A major feature of these sessions will be a round table discussion involving the speakers and the audience.For the detailed programme, please refer to pages 24-27.

Interactive Case SessionsCIRSE‘s Interactive Case Sessions are divided into several topics. After two presenters have shown individual cases, the audience is asked for its opinion on treatment. These interactive sessions provide an excellent learning experience on how to approach and work up difficult cases and deal with complications that may arise.

Morbidity & Mortality ConferenceThe Morbidity and Mortality Conference will analyse Interventio-nal Radiology cases which led to complications and/or deaths that could have been avoided. This session provides a valuable learn ing experience for everyone involved in Interventional Radiology. The session will be dedicated to vascular and non-vascular cases.

Satellite SymposiaSatellite Symposia are organised by industrial companies and take place at lunchtime as well as in the morning and in the evening in order to avoid time conflicts with the main scientific programme. During these sessions cutting-edge information on interventional equipment and techniques is provided.The Satellite Symposia programme will be published in the final programme.

Special Sessions Special Sessions are designed to impart the latest knowledge on topics of interest to interventional specialists. These sessions are the backbone of the CIRSE meeting and are specifically chosen by the programme planning committee because of their importance in daily practice.

WorkshopsDuring Workshops you will have the chance to learn from your colleagues’ expertise in an informal, interactive manner. Work-shops will entail individual cases and discussion points with regard to the particular interventional topic. Attendees can contribute their opinions and ask questions in small groups.

Exhibitors

Aachen ResonanceAbbott VascularALN Implants Chirurgicauxamedo Smart Tracking SolutionsAndanzaAndramedAngioDynamicsArgon Medical DevicesArtVentive MedicalAtriumB.Braun MedicalBardBayer HealthcareBiotequeBiotronikBolton MedicalBoston ScientificBraccoBSD MedicalCeloNova BioSciencesChongqing Haifu (HIFU) TechnologyCIDCIVCO Medical SolutionsControl Medical TechnologyCook MedicalCordis, Johnson & JohnsonCovidienCrux BiomedicalDelcath SystemsDePuy SynthesDFineEkosElastratEndocorEndologixeucatechEurocorGalil MedicalGEMGO MedicalGore & AssociatesHS Hospital ServiceImaging ManagementInSightecIntioiSYS Medizintechnik

Joline/transluminaKimalLifetech ScientificLombard MedicalMDT Medical InstrumentsMedcompMedex ResearchMedtronicMenticeMerit Medical SystemsMöller MedicalNeoRadNeuroThermNordionOlympus Surgical TechnologiesOptiMed Medizinische InstrumenteOscorPajunkPenumbraPerfint HealthcarePerouse MedicalphenoxPhilips Medical SystemsQessentialQualiMed Innovative MedizinprodukteRF MedicalSiemensSimbionixSirtex MedicalSpectraneticsSt. Jude MedicalSTARmedSterylabStraub MedicalSurefire MedicalSynergyTecresTeleflex MedicalTeraReconTerumoToshiba Medical SystemsTriVascularUreSilUrotechVascular SolutionsVidacare

Exhibitors

CIRSE’s technical exhibition features the largest and most comprehensive assembly of cutting edge equipment and devices for image-guided minimally invasive therapy in Europe. CIRSE would like to thank the following companies for their participation at CIRSE 2012 and looks forward to welcome them again in Barcelona for CIRSE 2013!

The CIRSE Annual Scientific and postgraduate Educational Meeting has established itself as the leading gathering for all professionals devoted to the field of Cardiovascular and Interventional Radiology in Europe. CIRSE 2012 saw an attendance of over 6,100 participants from 85 countries worldwide. More than 110 companies took the opportunity to promote their products.

Barcelona 2013 19

The EBIR is the European interventional radiologyqualification, and aims to standardise theprofession’s training and expertise in interventional radiology across Europe.

Certify your Expertise in Interventional Radiology

Register now for thenext EBIR examination,which will take place duringCIRSE 2013 in Barcelona.

For application deadlines and detailed information,please visit our website at www.cirse.org/ebir

The CIRSE EBIR DepartmentNeutorgasse 9/6, 1010 Vienna, Austriawww.cirse.org/[email protected]

C RSE

Don’t miss your chance!

European Board of Interventional RadiologyThe European qualification in Interventional Radiology

EB I R

Scientific Programme

Foundation Courses

Hot Topic Symposia

Evidence Forums


Saturday, September 14

Sunday, September 15

Monday, September 16

Tuesday, September 17

Wednesday, September 18

Hands-on Workshops

22-23

24-27

28-29

30

31-34

35-38

39-41

42-44

45

46-51

September 14-18Barcelona, Spain

CIRSE 2013

C RSE

The Essentials of Transcatheter Embolization


08:30-09:30 FC 101 Gastrointestinal haemorrhage:

how I do it

101.1 Diagnosis and localisation M. Darcy (St. Louis, MO/US) 101.2 Embolize upper GI haemorrhage R. Loffroy (Dijon/FR) 101.3 Embolize lower GI haemorrhage J. Golzarian (Minneapolis, MN/US) 101.4 Diagnose and treat chronic GI haemorrhage L. Defreyne (Ghent/BE)

10:00-11:00 FC 201 Female genito-urinary embolization:

how I do it

201.1 Manage life-threatening post-partum haemorrhage

O. Pellerin (Paris/FR) 201.2 Manage placental abnormalities J.-P. Pelage (Caen/FR) 201.3 Uterine artery embolization: patient

selection and technique T.J. Kroencke (Berlin/DE) 201.4 Ovarian vein embolization: patient

selection and technique A. Basile (Catania/IT)

11:30-12:30 FC 301 Vascular malformations: how I do it

301.1 Diagnosis: imaging strategy M. Köcher (Olomouc/CZ) 301.2 Treat peripheral low flow malformations J.P. Burnes (Clayton, VIC/AU) 301.3 Treat peripheral high flow malformations B. Peynircioglu (Ankara/TR) 301.4 Treat large visceral malformations J.E. Jackson (London/UK)

IN THE SPOTLIGHTFOuNDATION COuRSES

Foundation Courses cover a specific area of Interventional Radiology, focusing on basic principles and illustrating the procedure in a step-by-step fashion. They are designed for radiologists in training, new consultants and/or experienced consultants who require a refresher course on the subject. There will be plenty of time for questions and discussion. Each session lasts one hour. This year, the courses will cover the topics “Transcatheter Embolization”, “Neuro Interventions” and “Non-Vascular Interventions”.

IN THE SPOTLIGHTThe Essentials of Neuro Interventions


08:30-09:30 FC 901 Stroke management 1: how I do it

901.1 What do you need to know about imaging in acute stroke?

K.A. Hausegger (Klagenfurt/AT) 901.2 How to decide when to perform intra-

arterial thrombolysis/thrombectomy (IAT) A. Berlis (Augsburg/DE) 901.3 Logistics of IAT in acute stroke patients H. van Overhagen (The Hague/NL) 901.4 Which devices should I use in which

patients? A. Clifton (London/UK)

10:00-11:00 FC 1001 Stroke management 2: how I do it

1001.1 How I perform thrombolysis and thrombectomy

C. Castaño (Badalona Barcelona/ES) 1001.2 What influences the outcomes of IAT? to be announced 1001.3 Clinical outcomes after IAT – trial update P. Brennan (Dublin/IE) 1001.4 How to prevent and manage complications

of IAT R. Barranco Pons (Barcelona/ES)

The Essentials of Non-Vascular Interventions


11:30-12:30 FC 1101 Spine interventions: how I do it

1101.1 Spinal approach and bone biopsy R.-T. Hoffmann (Dresden/DE) 1101.2 Vertebroplasty A.D. Kelekis (Athens/GR) 1101.3 Balloon augmentation/stentoplasty C.A. Binkert (Winterthur/CH) 1101.4 Facet joints and discs D.K. Filippiadis (Athens/GR)


08:30-09:30 FC 1701 Biliary interventions: how I do it

1701.1 Biliary stenting and drainage B.S. Tan (Singapore/SG) 1701.2 Manage benign biliary strictures and stones M. Ryan (Dublin/IE) 1701.3 Percutaneous cholecystostomy A. Sibert (Clichy/FR) 1701.4 Manage complications of biliary and

gall bladder interventions D.F. Martin (Manchester/UK)

10:00-11:00 FC 1801 Biopsy and abscess drainage: how I do it

1801.1 Lung and mediastinal biopsy T. Sabharwal (London/UK) 1801.2 Abdominal and pelvic biopsy M. Düx (Frankfurt/DE) 1801.3 Empyema, lung abscess and mediastinal

drainage O. Akhan (Ankara/TR) 1801.4 Abdominal and pelvic abscess drainage P.R. Mueller (Boston, MA/US)

C RSE

The involvement of interventional radiology in the management of stroke has increased in recent years. This is in line with the rising prevalence of endovascular treatment modalities, including embolization for haemorrhagic stroke and thrombolysis, thrombectomy and recanalisation for ischaemic stroke. The timely application of these interventions has proven to be a beneficial addition to the armoury of stroke treatments.

As the incidence of stroke is set to rise with the ageing population, rapid access to the most advanced and effective treatments is not only of great importance today but will be even more so in the future. In order to guarantee the safe provision of sophisticated neurointerventional techniques it is vital that experienced and well-trained experts are available to meet demand.

Many interventional radiologists are already involved in endovascular stroke treatment by virtue of their relevant and extensive education, training and experience. Aside from the recognised advantages of general multidisciplinary stroke care, the involvement of other specialties in the delivery of endovascular treatments has become a topic of discussion, particularly regarding the establishment of common training programmes and the standardisation of competence.

Further to issues of individual competence are logistical concerns about how best to organise medical expertise to serve patient needs, in terms of both geographical coverage and quality of treatment.

The potentially huge growth in this field and the wider implications for IR of the connected issues means that discussion of this topic is as much of interest to general interventional radiologists as it is to those already closely involved in the area.

INTRA-ARTERIAL STROKE MANAGEMENT – SHOuLD THIS BE AN IR PROCEDuRE?

IN THE SPOTLIGHT

Sunday, September 15, 15:00-16:00

HTS 1302 Intra-arterial stroke management – should this be an IR procedure?

1302.1 Recent developments regarding the training of neuroradiologists and other specialties for neurointerventions

D. Vorwerk (Ingolstadt/DE) 1302.2 Intra-arterial thrombectomy should only be performed by dedicated neuroradiologists T. Andersson (Stockholm/SE) 1302.3 Intra-arterial thrombectomy can be safely performed by a well-trained

“general interventionalist“ K.A. Hausegger (Klagenfurt/AT) 1302.4 How much are general IRs involved in stroke therapy across Europe? D. Vorwerk (Ingolstadt/DE) 1302.5 A plan for the future involvement of IRs in the provision of acute stroke therapy J.A. Reekers (Amsterdam/NL)

Tommy Andersson Klaus A. Hausegger Jim A. Reekers Dierk Vorwerk

Hot Topic Symposium

The scientific programme at CIRSE 2013 features a range of sessions on the theory and practice of stroke management. The Hot Topic Symposium on intra-arterial stroke manage ment is a perfect complement to these sessions as it addresses concerns and issues around the provision of treatments including the balancing of quality and capacity. The session not only deals with the status quo but also looks ahead to how IR can be more strongly in tegrated into stroke management and how the best results for patients can be guaranteed.

As training is the foundation of procedural competence, Prof. Dierk Vorwerk (Ingolstadt/DE) will start the session with a description of recent developments relating to training frameworks for neuroradiologists as well as for other specialties who are involved in the delivery of neurointerventions.

The background to training having been explored, Dr. Tommy Andersson (Stockholm/SE) will continue by considering the provision of intra-arterial thrombectomy, which has had a large impact on modern stroke treatment and is set to become even more significant in the future. It is known that neurovascular centres with a high case load build greater expertise, in light of this the question of whether this important procedure should only be performed by dedicated neuroradiologists is up for discussion.

In the spirit of debate, Prof. Klaus Hausegger (Klagenfurt/AT) will respond by considering whether well trained “general interventionalists“ have the necessary skills and knowledge to safely perform intra-arterial thrombectomy and what implications this may have for ser vice provision. Having established this, Prof. Dierk Vorwerk will again take to the podium to consider the extent to which general IRs are already involved in stroke therapy across Europe.

Prof. Jim Reekers (Amsterdam/NL) will conclude the session by discussing possible strategies for the future involvement of IRs in the provision of acute stroke therapy and what this would mean for IR and for patient care.

IN THE SPOTLIGHT


C RSE

TREATMENT OF LuNG CANCER – THE CHOICES, AND HOW TO MAKE THEM

Interventional oncology has been making incredible progress in recent years, and already, IR therapies for liver cancers are well accepted and widely used. However, exacting research is also being conducted into other cancer types, with some impressive results.

Lung cancer therapy is an area where IR is showing real potential. Various principles (thermal ablation; mechanical ablation; embolization) have been investigated in lung tumour models, and data is now available to support their use in certain clinical settings, particularly radiofrequency ablation.

Good patient selection is a crucial factor in achieving positive outcomes. A thorough knowledge of the technology to be used is essential, as is an awareness of the limitations of the planned treatment.

Patient selection

So far, data suggest that the ideal RFA candidate suffers from stage I non-small cell lung cancer (NSCLC) which is either surgically inoperable or at high risk for lobectomy or pneumo nectomy. Multiple studies show that tumours to be treated by RFA should be <3cm, as it is difficult to ensure complete ablation in larger targets. Location <1cm from the main bron chi is an absolute contraindication, as is association with atelectasis or obstructive pneumo nitis, and unmanageable coagulopathy. However, contact with the visceral pleura is not a contraindication, as possible pleural effusion or increased pain can be easily managed.

Although it is currently accepted that RFA should be reserved for surgically inoperable patients (largely due to the associated difficulty in assuring complete tumour destruction and in sampling the tumour tissue), data from the Institut Gustave Roussy suggests that this prescription may not be absolute: strangely, their study reported better survival out comes for the >70 age group. This anomaly is most likely due to the inclusion criteria – patients below this age were those deemed inoperable due to the tumour location or co-morbidities, while all patients over 70 were deemed inoperable primarily due to their age, and thus RFA was performed on less complex tumour presentations in that age group.Nonetheless, good patient selection remains a key indicator of outcomes, along with suitable imaging, anaesthesia and patient positioning (both in terms of trajectory of the needle and tumour mobility).

Technical limitations

Understanding the limitations of your technology is also crucial, and can allow creative so lutions to possible complications. Thermal damage to nerves and other structures can be avoided by judicious use of air protection or a fluid buffer, such as a 5% glucose solution.

RFA and other thermal technologies can be negatively affected by vessel proximity, as the heat-sink effect prevents a complete ablation. There are several options to overcome this limitation, including sequential activation or use of an alternative energy source, such as microwave ablation or irreversible electroporation. MWA also allows larger burn-zones, which allows for the destruction of more bulky tumours.

IN THE SPOTLIGHT

Barcelona 2013 27


Hot Topic Symposium

This Hot Topic Symposium will approach the topic from a number of angles, painting a full picture of the considerations and skills needed to provide these cutting-edge therapies.

Dr. José Vilar (Valencia/ES) will be discussing the imaging modalities available to guide the treatment of lung cancer. CT modalities are currently the most widely used, with spiral CT enjoying favour among many who are investigating ablation of lung cancers. Fluoro-CT can offer contrast-free imaging, while contrast-enhanced CT can demonstrate morphology and enhancement pattern. The use of PET-CT and diffusion-weighted MR are also under investigation for this treatment.

Various forms of thermal ablation will be discussed by Dr. Thierry de Baère (Villejuif/FR), who has been researching this field for many years, and who was one of the authors in the Institut Gustave Roussy study. Dr. de Baère will present the data from leading studies, and analyse whether this data indicates that thermal ablation for NSCLC should be offered routinely as part of a hospital’s oncology regimens.

Prof. Afshin Gangi (Strasbourg/FR) will examine the case for the use of cryotherapy in the lungs and thoracic wall, using his own extensive research and data to give the most up-to-date overview of this novel therapy. Although less widely used than technologies like RFA or MWA, cryotherapy offers a number of unusual features that can be of benefit in tumour destruction, and Prof. Gangi will discuss whether these benefits transfer well to the pulmonary setting.

To ensure a valuable balance in these discussions, radiation oncologist Dr. Lisbeth Kenny (Brisbane, QLD/AU) will offer her insights into choosing the right therapy for a lung cancer patient. She will weigh up not only how to decide whether a patient should receive treatment for their particular condition, but if so, how the correct course of therapy can be selected by a multidisciplinary team.

Tuesday, September 17, 13:30-14:30

HTS 2802 Treatment of lung cancer – the choices, and how to make them

2802.1 The role of imaging in guiding the treatment of lung cancer J. Vilar (Valencia/ES) 2802.2 Thermal ablation: research or mainstream therapy? T. de Baère (Villejuif/FR) 2802.3 Percutaneous cryotherapy in the lungs and the thoracic wall A. Gangi (Strasbourg/FR) 2802.4 Radiation therapy: the oncologist’s view of how to choose whether and how to treat L.M. Kenny (Brisbane, QLD/AU)

Thierry de Baère Afshin Gangi Lizbeth M. Kenny José Vilar

IN THE SPOTLIGHT

Evidence forum: SFA – do we know the optimal treatment yet?

A range of devices and techniques are now available for revascularisation of the superficial femoral artery in peripheral arterial disease. These treatments offer great potential in reducing morbidity and restoring quality of life. However, in light of the latest studies and the volume of data now available there is a need to compare strategies carefully. This is essential if interventional radiologists are to offer an optimal and evidence-based approach for each patient.

In this forum, clinical data on a wide spectrum of endovascular SFA technologies will be compared, including drug-eluting and covered stents as compar ed to bare metal stents, as well as drug-eluting balloons and atherectomy with cutting balloons.

The session will end with a summary of the evidence and conclusions will be drawn by the experts in a pa-nel discussion, considering if there is indeed a current “optimal treatment” or if further investigations and longer term trial results are needed in particular areas.

Sunday, September 15, 11:30-12:30

SS 1102 Evidence forum: SFA – do we know the optimal treatment yet?

1102.1 Bare metallic stents S. Müller-Hülsbeck (Flensburg/DE) 1102.2 Drug-eluting stents P.A. Gaines (Sheffield/UK) 1102.3 Stent-grafts M. Schoder (Vienna/AT) 1102.4 Drug-eluting balloons G. Tepe (Rosenheim/DE) 1102.5 Atherectomy, cutting balloons M.S. Hamady (London/UK) 1102.6 Summary of evidence and panel discussion

CIRSE ConSIdERS thE EvIdEnCE

Keeping pace with the latest developments in interventional medicine, CIRSE 2013 sees the introduction of a new session type into the scientific programme. Evidence Forums will see the most up-to-date research summarised and discussed in the context of relevant questions arising in current practice. Among the topics this year are superficial femoral artery interventions and below-the-knee interventions, in both cases the question will be asked whether we know the optimal treatment yet.

IN THE SPOTLIGHT

Image courtesy of Prof. Stefan Müller-Hülsbeck

SFA and BtK interventions

Peripheral arterial disease is on the rise, and is a cause for great concern. As the traditional response to the ischaemia and non-healing ulcers that arise from this disease is amputation, it can be costly in both economic and social terms. A commonly quoted figure is that somewhere in the world, a leg will be lost to diabetes every 30 seconds. Even with the wealth of IR options available, up to 67% of CLI patients in the uSA have a primary amputa tion as their initial treatment – a staggering figure when one considers that recanalisation techniques can lower the amputation rate in CLI patients from 73-95% down to just 25%.

Evidence forum: BTK – do we know the optimal treatment yet?

Below-the-knee interventions rightly occupy an important place in the armoury of IR procedures. Not only can they be considered the first true IR therapy, but their refinement over the last 50 years, in tandem with the simultaneous rise in both life-expectancy and incidence of diabetes, leaves below-the-knee interventions more needed than ever.

PTA is widely held to be the primary treatment for lower-limb occlusions, and despite high restenosis rates, it achieves excellent limb-salvage results. Retreatment is always an option, and assisted and secondary patency rates are very high. Advances in stent and balloon technologies (along with dedicated catheters and guidewires) allow IRs to treat a wide range of BTK lesions, both long and short.

However, navigating all these options can prove diffi-cult, and an overview of the evidence and indications for some of these techniques and tools will be provided by experts in the field, followed by a panel discussion and questions from the audience.

Monday, September 16, 08:30-09:30

SS 1702 Evidence forum: BTK – do we know the optimal treatment yet?

1702.1 PTA J.H. Peregrin (Prague/CZ) 1702.2 Bare stents T. Jahnke (Neumünster/DE) 1702.3 Drug-eluting balloons M. Di Primio (Paris/FR) 1702.4 Drug-eluting stents T.W.I. Clark (Philadelphia, PA/US) 1702.5 Stem cell and gene therapy S. Sharma (Delhi/IN) 1702.6 Summary of evidence and panel discussion

NEWIN THE SPOTLIGHT

Image courtesy of Dr. Massimiliano Di Primio


C RSE


Workshops for radiographers

A series of two workshops organised in co-operation with the


10:00-11:00 RWS 206 EFRS Workshop 1 Organization and operational standards for

IR service

206.1 C. Ciaralli (Rome/IT) 206.2 S. Panci (Florence/IT)

Learning objectivesAfter active participation in this workshop including the pre-sentation of the AITRI (Italian Association of Interventional Radiographers) guidelines, attendees will have gained better knowledge and understanding of:• the activities and methods necessary to establish an Inter-

ventional Radiology (IR) service according to the volume and type of diagnostic tests and therapeutic treatments performed

• how to evaluate the needs (materials and devices) of the IR service and how to supply and manage human resources

• the level of collaboration necessary between the different professionals involved (interaction, tasks and competences)

• the responsibility of radiation protection and supervision of the maintenance of operational standards and appropriate criteria

• training and up-to-date courses for health professionals


10:00-11:00 RWS 1006 EFRS Workshop 2 Radiation protection for patients and staff

in interventional procedures

1006.1 R.D. Silkoset (Østerås/NO) 1006.2 A. Widmark (Østerås/NO)

Learning objectivesAfter active participation in this workshop attendees will have gained better knowledge and understanding of:• the principles of radiological protection in fluoroscopically

guided interventions• protection of staff during interventional fluoroscopy• recommended radiological protection training for staff• the radiation risk factors and possible harm in Interventional

Radiology for staff and patients – dose limits for staff – the eye lense and radiation (cataract) – examples of tissue reactions

Interventional Radiology is very much a team effort. Optimal patient care can only be delivered if the physician and the other team members, such as radiographers, are well trained and highly professional in what they do.

A growing number of radiographers working in the field of Interventional Radiology are attending the annual CIRSE congress. In order to cater to this development, CIRSE and the European Federation of Radiographer Societies (EFRS) are organising two interactive workshops especially designed for radiographers and nurses.

Barcelona 2013 31



08:30-09:30 SS 104 Special Session Advances in image guidance for

interventional oncology procedures

104.1 New developments in guidance and navigation N. Abi-Jaoudeh (Bethesda, MD/US) 104.2 Non-contrast fusion road-mapping:

how can it help? M.J.L. van Strijen (Nieuwegein/NL) 104.3 Stereotaxy and robotic assistance:

where are we now? R. Bale (Innsbruck/AT) 104.4 Intraprocedural evaluation G. Soulez (Montreal, QC/CA)

08:30-13:00 PTP-HoW 1 Hands-on Workshop Principles to practice: education and

simulation skills training / renal denervation

Coordinators: D.O. Kessel (Leeds/UK), I. Robertson (Glasgow/UK)

PTP 1.1 Group 1 (08:30-10:40) PTP 1.2 Group 2 (09:40-11:50) PTP 1.3 Group 3 (10:50-13:00)

10:00-11:00 FC 201 Foundation Course Female genito-urinary embolization:

how I do it

201.1 Manage life-threatening post-partum haemorrhage O. Pellerin (Paris/FR) 201.2 Manage placental abnormalities J.-P. Pelage (Caen/FR) 201.3 Uterine artery embolization: patient selection

and technique T.J. Kroencke (Berlin/DE) 201.4 Ovarian vein embolization: patient selection

and technique A. Basile (Catania/IT)


08:30-09:30 FC 101 Foundation Course Gastrointestinal haemorrhage: how I do it

101.1 Diagnosis and localisation M. Darcy (St. Louis, MO/US) 101.2 Embolize upper GI haemorrhage R. Loffroy (Dijon/FR) 101.3 Embolize lower GI haemorrhage J. Golzarian (Minneapolis, MN/US) 101.4 Diagnose and treat chronic GI haemorrhage L. Defreyne (Ghent/BE)

08:30-09:30 SS 102 Special Session upper extremity PVD

102.1 Optimal imaging assessment for supra-aortic and upper limb arterial disease

C. Hohl (Siegburg/DE) 102.2 How can we improve our results for the treatment

of subclavian artery occlusions? – Tips and tricks S. Macdonald (Newcastle-upon-Tyne/UK) 102.3 Is there a role for PTA and/or stenting for disease

distal to the subclavian arteries? S.D. Qanadli (Lausanne/CH) 102.4 How should we treat aneurysms and pseudo-

aneurysms of the upper extremity arteries? E. Brountzos (Athens/GR)

08:30-09:30 SS 103 Special Session Training and accreditation for IRs

103.1 How does IR training vary across Europe? P. Reimer (Karlsruhe/DE) 103.2 How will the EBIR and the new curriculum help

training and accreditation? A.-M. Belli (London/UK) 103.3 Arguments for and against recertification J.A. Kaufman (Portland, OR/US) 103.4 Should IR become a separate subspecialty? I. Robertson (Glasgow/UK)

C RSE

10:00-11:00 SS 205 Special Session Gastrointestinal and genito-urinary

interventions forum

205.1 Sclerotherapy of renal and hepatic cysts O. Akhan (Ankara/TR) 205.2 Current status of upper GI stenting H.-Y. Song (Seoul/KR) 205.3 Biodegradable, retrievable and drug-eluting stents

in the biliary tract M.E. Giménez (Buenos Aires/AR) 205.4 Fallopian tube recanalization M. Szczerbo-Trojanowska (Lublin/PL)

10:00-11:00 RWS 206 EFRS Workshop 1 Organization and operational standards for

IR service

206.1 C. Ciaralli (Rome/IT) 206.2 S. Panci (Florence/IT)

11:30-12:30 FC 301 Foundation Course Vascular malformations: how I do it

301.1 Diagnosis: imaging strategy M. Köcher (Olomouc/CZ) 301.2 Treat peripheral low flow malformations J.P. Burnes (Clayton, VIC/AU) 301.3 Treat peripheral high flow malformations B. Peynircioglu (Ankara/TR) 301.4 Treat large visceral malformations J.E. Jackson (London/UK)

11:30-12:30 ICS 302 Interactive Case Session Challenging lower limb recanalization

302.1 L. Boyer (Clermont-Ferrand/FR) 302.2 D. Karnabatidis (Patras/GR)

10:00-11:00 SS 202 Special Session Aortoiliac disease

202.1 Which is the best imaging modality for preprocedural assessment?

M. Das (Maastricht/NL) 202.2 Are re-entry devices useful in chronic

iliac occlusions? A. Buecker (Homburg/DE) 202.3 Do we know the best treatment for different

TASC lesions: PTA vs. bare metal stents vs. covered stents

T. Rand (Vienna/AT) 202.4 Can interventional radiologists treat acute

aortoiliac artery occlusion? W. Jaschke (Innsbruck/AT)

10:00-11:00 SS 203 Special Session Preventative stroke management

203.1 What we know about atherosclerotic plaques: non-invasive morphologic imaging

A.H. Mahnken (Marburg/DE) 203.2 Prevention of imminent or recurrent stroke with

medical therapy or non-radiologic intervention H.S. Markus (London/UK) 203.3 Extracranial stenting: indications and techniques A. González García (Sevilla/ES) 203.4 Intracranial stenting: indications and techniques C.P. Stracke (Bonn/DE)

10:00-11:00 SS 204 Special Session New clinical applications for

interventional oncologists 1

204.1 Desmoid tumours G. Tsoumakidou (Strasbourg/FR) 204.2 Malignant melanoma C.W. Nutting (Englewood, CO/US) 204.3 Neuroendocrine tumours F. Orsi (Milan/IT) 204.4 Cholangiocarcinoma J.B. Karani (London/UK)

32 Saturday, September 14 The Wave of Innovation

Saturday, September 14Barcelona 2013 33


14:30-16:00 OP 501 CIRSE Opening Ceremony and Awards

16:00-17:30 TA-HoW 2 Hands-on Workshop Tumour ablation: tips and tricks /

starting your practice

Coordinators: T.K. Helmberger (Munich/DE), A.D. Kelekis (Athens/GR)

16:15-17:15 WS 601 Workshop Advanced SFA and BTK interventions:

case-based discussions

601.1 R. Gandini (Rome/IT) 601.2 M. Manzi (Abano Terme/IT)

16:15-17:15 WS 602 Workshop Paediatric vascular interventions

602.1 A.M. Cahill (Philadelphia, PA/US) 602.2 A.M. Barnacle (London/UK)

16:15-17:15 WS 603 Workshop Venous lysis and stenting

603.1 T.-E.G. Vrachliotis (Athens/GR) 603.2 F. Boyvat (Ankara/TR)

16:15-17:15 WS 604 Workshop Advanced uFE: case-based discussions

604.1 N. Hacking (Southampton/UK) 604.2 J. Maskova (Aberdeen/UK)

16:15-17:15 WS 605 Workshop Peripheral bone interventions: how I do it

605.1 C.S.P. van Rijswijk (Leiden/NL) 605.2 G. Carrafiello (Varese/IT)

16:15-17:15 WS 606 Workshop How to manage neuroendocrine tumours

606.1 W.S. Rilling (Milwaukee, WI/US) 606.2 L. Monfardini (Milan/IT)

11:30-12:30 SS 303 Special Session Hepatic, portal and mesenteric vein thrombosis

303.1 Clinical presentation and management of hepatic vein occlusive disease

Y.H. Kim (Daegu/KR) 303.2 IR management of Budd-Chiari syndrome A. Krajina (Hradec Králové/CZ) 303.3 Clinical presentation and medical management of

acute and chronic portomesenteric vein thrombosis J.C. García-Pagán (Barcelona/ES) 303.4 IR management of acute and chronic

portomesenteric vein thrombosis I.K. Tesdal (Friedrichshafen/DE)

11:30-12:30 ICS 304 Interactive Case Session Kidney and lung ablations

304.1 J. Palussière (Bordeaux/FR) 304.2 X. Buy (Bordeaux/FR)

11:30-12:30 SS 305 Special Session Anaesthesia, sedation and analgesia for IR

305.1 Perioperative care: pre-operative patient assess-ment, optimization and post-operative care

B. Preckel (Amsterdam/NL) 305.2 Sedation and analgesia techniques in IR:

a practical approach A. Vari (Rome/IT) 305.3 Anaesthesia techniques in IR: a practical approach C. Batistaki (Athens/GR) 305.4 Locoregional techniques: local anaesthetics to

nerve block X. Sala Blanch (Barcelona/ES)

12:45-14:15 IVC-HoW 1 Hands-on Workshop IVC filters

Coordinators: O. Pellerin (Paris/FR), A.F. Watkinson (Exeter/UK)


starting your practice


13:00-14:00 Satellite Symposia

16:15-17:15 WS 607 Workshop Revascularization tools, tips and tricks in

stroke management: case-based discussions

607.1 R. Chapot (Essen/DE) 607.2 H. Henkes (Stuttgart/DE)


17:00-18:30 CD-HoW 1 Hands-on Workshop A closer look at closure devices

Coordinators: S. Müller-Hülsbeck (Flensburg/DE), J. Tacke (Passau/DE)

17:30-18:30 WS 701 Workshop Renal artery interventions:

all you need to know

701.1 M.W. de Haan (Maastricht/NL) 701.2 K.E. Wilhelm (Bonn/DE)

17:30-18:30 WS 702 Workshop Tunnelled central venous catheters and ports:

how I do it

702.1 B.S. Funaki (Chicago, IL/US) 702.2 J.M. Lozano (Bogota/CO)

17:30-18:30 WS 703 Workshop Varicocele and ovarian vein embolization:


703.1 A.C. Roberts (La Jolla, CA/US) 703.2 T. Jargiello (Lublin/PL)

17:30-18:30 WS 704 Workshop Trauma: case-based discussions

704.1 P.E. Andersen (Odense/DK) 704.2 J. Urbano (Madrid/ES)

17:30-18:30 WS 705 Workshop ABC of biliary intervention:


705.1 A. Hatzidakis (Iraklion/GR) 705.2 M. Grosso (Cuneo/IT)

17:30-18:30 WS 706 Workshop Prostate artery embolization: how I do it

706.1 J.M. Pisco (Lisbon/PT) 706.2 F.C. Carnevale (São Paulo/BR) 706.3 J. Golzarian (Minneapolis, MN/US)

17:30-18:30 WS 707 Workshop Fundamentals of intracerebral aneurysms

and AVM treatment

707.1 M. Piotin (Paris/FR) 707.2 C. Cognard (Toulouse/FR)

34 The Wave of InnovationSaturday, September 14

C RSE

Sunday, September 15Barcelona 2013 35


08:30-09:30 SS 904 Special Session Prostate artery embolization:

real benefit or myth?

904.1 Benign prostatic hypertrophy – the scope of the problem

N. Thiounn (Paris/FR) 904.2 How can we identify the prostatic arteries during

the procedure? O. Pellerin (Paris/FR) 904.3 How to perform PAE: tips and tricks F.C. Carnevale (São Paulo/BR) 904.4 What do we know about outcomes of

embolization in 2013? J.M. Pisco (Lisbon/PT)

08:30-09:30 SS 905 Special Session Renal tumour ablation

905.1 Patient selection: treatment or active surveillance? J. Tacke (Passau/DE) 905.2 Biopsy, always before ablation? A.R. van Erkel (Leiden/NL) 905.3 Thermal vs. cryotherapy vs. nephron sparing

surgery – do we know the answer? D.J. Breen (Southampton/UK) 905.4 Complications after thermal ablation and

cryothe rapy of renal tumours: detection and management

X. Buy (Bordeaux/FR)

08:30-10:00 VV-HoW 1 Hands-on Workshop Varicose veins

Coordinators: C.A. Binkert (Winterthur/CH), K.D. McBride (Dunfermline/UK)

08:30-13:00PTP-HoW 2 Hands-on Workshop Principles to practice: education and simulation

skills training / peripheral vascular disease: getting better outcomes in limb ischaemia





08:30-09:30 FC 901 Foundation Course Stroke management 1: how I do it

901.1 What do you need to know about imaging in acute stroke?

K.A. Hausegger (Klagenfurt/AT) 901.2 How to decide when to perform intra-arterial

thrombolysis/thrombectomy (IAT) A. Berlis (Augsburg/DE) 901.3 Logistics of IAT in acute stroke patients H. van Overhagen (The Hague/NL) 901.4 Which devices should I use in which patients? A. Clifton (London/UK)

08:30-09:30 SS 902 Special Session Abdominal aorta – update

902.1 Has the percutaneous approach for EVAR reduced access site complications?

F. Fanelli (Rome/IT) 902.2 Do the new EVAR devices enable us to treat more

patients more effectively? A. Holden (Auckland/NZ) 902.3 Trials update for elective and emergency EVAR A. Chavan (Oldenburg/DE) 902.4 Medium and long term outcomes after

fenestrated EVAR – do devices migrate? A. England (Liverpool/UK)

08:30-09:30 SS 903 Special Session Haemodialysis

903.1 Is shunt surveillance useful: why and how? M. Roček (Prague/CZ) 903.2 The role of IR in the management of

non-maturing fistulas L. Turmel-Rodrigues (Tours/FR) 903.3 The role of stents and stent grafts in the

management of failing AV grafts and fistulas R.B. Shoenfeld (West Orange, NJ/US) 903.4 Venous access options when the thoracic central

veins are lost M. Guimaraes (Charleston, SC/US)

C RSE

10:00-11:00 SS 1004 Special Session uterine artery embolization

1004.1 Imaging pre and post uterine artery embolization – how good are new imaging techniques?

L.S. Fournier-Dujardin (Paris/FR) 1004.2 What do we know about uterine-ovarian anasto-

moses and uterine artery embolization outcomes? J.-P. Pelage (Caen/FR) 1004.3 How good is uterine artery embolization for

adenomyosis: what do we know? P.N.M. Lohle (Tilburg/NL) 1004.4 Uterine artery embolization vs. myomectomy:

trials update J.B. Spies (Washington, DC/US)

10:00-11:00 SS 1005 Special Session Irreversible electroporation – true revolution?

1005.1 Status of technology T.K. Helmberger (Munich/DE) 1005.2 Liver applications L. Crocetti (Pisa/IT) 1005.3 Pancreatic applications G. Narayanan (Miami, FL/US) 1005.4 Imaging after irreversible electroporation M. Abdel Rehim (Clichy-Paris/FR)

10:00-11:00 RWS 1006 EFRS Workshop 2 Radiation protection for patients and staff

in interventional procedures

1006.1 R.D. Silkoset (Østerås/NO) 1006.2 A. Widmark (Østerås/NO)

10:30-12:30VAT-HoW 1 Hands-on Workshop Vertebral augmentation techniques /

vertebroplasty

Coordinators: J. Garnon (Strasbourg/FR), G. Tsoumakidou (Strasbourg/FR)

11:15-12:45 RD-HoW 1 Hands-on Workshop Renal denervation Coordinators: F. Fanelli (Rome/IT),

G.S. Goh (London/UK)

10:00-11:00 FC 1001 Foundation Course Stroke management 2: how I do it

1001.1 How I perform thrombolysis and thrombectomy C. Castaño (Badalona Barcelona/ES) 1001.2 What influences the outcomes of IAT? to be announced 1001.3 Clinical outcomes after IAT – trial update P. Brennan (Dublin/IE) 1001.4 How to prevent and manage complications of IAT R. Barranco Pons (Barcelona/ES)

10:00-11:00 SS 1002 Special Session Thoracic aorta – update

1002.1 How good is TEVR for aortic trauma – do the new devices enable a definitive solution?

T. Pfammatter (Zurich/CH) 1002.2 Adverse outcomes after TEVR: a risk scoring

system for everyday use I. Loftus (London/UK) 1002.3 What recent developments help us to treat disease

in the ascending aorta and aortic arch? M.D. Dake (Stanford, CA/US) 1002.4 What is the current role of branched endografts in

thoracoabdominal aneurysms and dissections? E.L. Verhoeven (Nuremberg/DE)

10:00-11:00 SS 1003 Special Session Renal denervation

1003.1 How you can develop this procedure in your hospital

A.-M. Belli (London/UK) 1003.2 How do I decide between all of the devices

and techniques? M.R. Sapoval (Paris/FR) 1003.3 Complications and their management P. Reimer (Karlsruhe/DE) 1003.4 What is the evidence for efficacy? J.A. Reekers (Amsterdam/NL)

36 The Wave of InnovationSunday, September 15

Sunday, September 15Barcelona 2013 37


11:30-12:30 SS 1104 Special Session Embolization in the thorax

1104.1 Modern imaging strategy for haemoptysis A.M. Madureira (Porto/PT) 1104.2 Basic and advanced techniques for bronchial

artery embolization F. Wolf (Vienna/AT) 1104.3 How to treat pulmonary artery aneurysms and

vascular malformations J.A. Vos (Nieuwegein/NL) 1104.4 Blunt and penetrating trauma P. Minko (Homburg/DE)

11:30-12:30 ICS 1105 Interactive Case Session Combined treatments in liver cancer

1105.1 L. Hechelhammer (St. Gallen/CH) 1105.2 A.N. Chatziioannou (Athens/GR)

11:30-12:30 SS 1106 Special Session Radiation dose management

1106.1 Understanding pros and cons of the new X-ray systems in improvement of radiation safety and image quality

E. Vano (Madrid/ES) 1106.2 What is the real risk of radiation-induced cataracts

for interventionists? M. Bezzi (Rome/IT) 1106.3 Hybrid rooms for IR: how to plan a good radiation

safety programme G.N. Paulo (Coimbra/PT) 1106.4 Efficient dose management as a result of

preplanning image-guided IR procedures G. Bartal (Kfar-Saba/IL)



11:30-12:30 FC 1101 Foundation Course Spine interventions: how I do it 1101.1 Spinal approach and bone biopsy R.-T. Hoffmann (Dresden/DE) 1101.2 Vertebroplasty A.D. Kelekis (Athens/GR) 1101.3 Balloon augmentation/stentoplasty C.A. Binkert (Winterthur/CH) 1101.4 Facet joints and discs D.K. Filippiadis (Athens/GR)

11:30-12:30 SS 1102 Special Session Evidence forum:

SFA – do we know the optimal treatment yet?

1102.1 Bare metallic stents S. Müller-Hülsbeck (Flensburg/DE) 1102.2 Drug-eluting stents P.A. Gaines (Sheffield/UK) 1102.3 Stent-grafts M. Schoder (Vienna/AT) 1102.4 Drug-eluting balloons G. Tepe (Rosenheim/DE) 1102.5 Atherectomy, cutting balloons M.S. Hamady (London/UK) 1102.6 Summary of evidence and panel discussion

11:30-12:30 SS 1103 Special Session Controversies in portal hypertension

1103.1 TIPS should be primary therapy for refractory ascites: Pro

J.I. Bilbao (Pamplona/ES) 1103.2 TIPS should be primary therapy for

refractory ascites: Con J.C. García-Pagán (Barcelona/ES) 1103.3 TIPS should be primary therapy for severe

variceal haemorrhage: Pro G.M. Richter (Stuttgart/DE) 1103.4 TIPS should be primary therapy for severe

variceal haemorrhage: Con P.E. Huppert (Darmstadt/DE) 1103.5 Gastric variceal haemorrhage after failed

endoscopic therapy: BRTO S. Hirota (Nishinomiya/JP) 1103.6 Gastric variceal haemorrhage after failed

endoscopic therapy: TIPS Z.J. Haskal (Baltimore, MD/US)

12:45-14:15 TA-HoW 3 Hands-on Workshop Tumour ablation: tips and tricks / liver



14:30-16:00 Andreas Gruentzig Lecture /

Hot Topic Symposium

HL 1301 Andreas Gruentzig Lecture

1301.1 EVAR for AAA – evolution or revolution? A. Holden (Auckland/NZ)

HTS 1302 Intra-arterial stroke management – should this be an IR procedure?

1302.1 Recent developments regarding the training of neuroradiologists and other specialties for neurointerventions

D. Vorwerk (Ingolstadt/DE) 1302.2 Intra-arterial thrombectomy should only be

performed by dedicated neuroradiologists T. Andersson (Stockholm/SE) 1302.3 Intra-arterial thrombectomy can be safely perform-

ed by a well trained “general interventionalist” K.A. Hausegger (Klagenfurt/AT) 1302.4 How much are general IRs involved in stroke

therapy across Europe? D. Vorwerk (Ingolstadt/DE) 1302.5 A plan for the future involvement of IRs in the

provision of acute stroke therapy J.A. Reekers (Amsterdam/NL)


16:00-17:30 EMT-HoW 1 Hands-on Workshop Embolization: materials and tools / coils & plugs

Coordinators: S.J. McPherson (Leeds/UK), E.M. Walser (Galveston, TX/US)


bone and soft tissue


16:15-17:15 Free Papers



17:30-18:30 WS 1501 Workshop Advanced aortoiliac interventions:


1501.1 M.B. Matson (London/UK) 1501.2 D.K. Tsetis (Iraklion/GR)

17:30-18:30 WS 1502 Workshop IVC filters: what you need to know

1502.1 M.F. Given (Dublin/IE) 1502.2 A.F. Watkinson (Exeter/UK)

17:30-18:30 WS 1503 Workshop GI haemorrhage: case-based discussions

1503.1 F. Melchiorre (Milan/IT) 1503.2 C.E. Ray (Golden, CO/US)

17:30-18:30 WS 1504 Workshop Acute pancreatitis: case-based discussions

1504.1 E.M. Walser (Galveston, TX/US) 1504.2 V. Válek (Brno/CZ)

17:30-18:30 WS 1505 Workshop How I do renal tumour ablation:

RFA and cryotherapy

1505.1 A. Veltri (Orbassano/IT) 1505.2 J. Garnon (Strasbourg/FR)

17:30-18:30 WS 1506 Workshop How to treat epistaxis: case-based discussions

1506.1 A.D. Platts (London/UK) 1506.2 A.M. Al-Kutoubi (Beirut/LB)


38 The Wave of InnovationSunday, September 15

Monday, September 16Barcelona 2013 39


08:30-09:30 ICS 1704 Interactive Case Session Haemorrhage

1704.1 G.A. Maleux (Leuven/BE) 1704.2 E. Atar (Petah Tikva/IL)

08:30-09:30 SS 1705 Special Session Treatment synergies in liver tumours

1705.1 TACE and systemic treatment in HCC J.-F.H. Geschwind (Baltimore, MD/US) 1705.2 Thermal ablation and TACE in the treatment of HCC R. Lencioni (Pisa/IT) 1705.3 Intra-arterial and systemic treatments in

colorectal metastases to be announced 1705.4 Optimal sequence of ablation and chemotherapy

in colorectal metastases A. Gillams (London/UK)


skills training / emergency EVAR: assessment and deployment



10:00-11:00 FC 1801 Foundation Course Biopsy and abscess drainage: how I do it

1801.1 Lung and mediastinal biopsy T. Sabharwal (London/UK) 1801.2 Abdominal and pelvic biopsy M. Düx (Frankfurt/DE) 1801.3 Empyema, lung abscess and mediastinal drainage O. Akhan (Ankara/TR) 1801.4 Abdominal and pelvic abscess drainage P.R. Mueller (Boston, MA/US)



08:30-09:30 FC 1701 Foundation Course Biliary interventions: how I do it

1701.1 Biliary stenting and drainage B.S. Tan (Singapore/SG) 1701.2 Manage benign biliary strictures and stones M. Ryan (Dublin/IE) 1701.3 Percutaneous cholecystostomy A. Sibert (Clichy/FR) 1701.4 Manage complications of biliary and

gall bladder interventions D.F. Martin (Manchester/UK)


BTK – do we know the optimal treatment yet?

1702.1 PTA J.H. Peregrin (Prague/CZ) 1702.2 Bare stents T. Jahnke (Neumünster/DE) 1702.3 Drug-eluting balloons M. Di Primio (Paris/FR) 1702.4 Drug-eluting stents T.W.I. Clark (Philadelphia, PA/US) 1702.5 Stem cell and gene therapy S. Sharma (Delhi/IN) 1702.6 Summary of evidence and panel discussion

08:30-09:30 SS 1703 Special Session Carotid and vertebral artery intervention

1703.1 Current optimal imaging strategy for the assess-ment and follow-up before and after carotid intervention

P. Brennan (Dublin/IE) 1703.2 Stenting vs. endarterectomy vs. medical therapy

trials update P.R. Taylor (London/UK) 1703.3 Which patients benefit from vertebral

artery intervention? A. Clifton (London/UK) 1703.4 Techniques and outcomes of vertebral

artery angioplasty/stenting P. Haage (Wuppertal/DE)

10:00-11:00 SS 1802 Special Session Controversies in aortic intervention

1802.1 Chimneys and periscopes can replace fenestrated and branched endografts: Pro

J. Hardman (Bath/UK) 1802.2 Chimneys and periscopes can replace fenestrated

and branched endografts: Con M.A. Funovics (Vienna/AT) 1802.3 Multilayered stents have a role in aortic

aneurysm: Pro M.A. Ruffino (Turin/IT) 1802.4 Multilayered stents have a role in aortic

aneurysm: Con T. Rand (Vienna/AT) 1802.5 Evidence supports TEVR in patients with

uncomplicated acute type B dissection: Pro J.-P. Beregi (Nîmes/FR) 1802.6 Evidence supports TEVR in patients with

uncomplicated acute type B dissection: Con P.R. Taylor (London/UK)

10:00-11:00 SS 1803 Special Session Varicose veins

1803.1 Which patients should we treat? J.A. Kaufman (Portland, OR/US) 1803.2 Endothermal vein ablation: step by step C.A. Binkert (Winterthur/CH) 1803.3 What other endovenous techniques can we use? K.D. McBride (Dunfermline/UK) 1803.4 How can IRs set up a varicose vein

ablation service? D.J. West (Stoke-on-Trent/UK)

10:00-11:00 SS 1804 Special Session Visceral artery aneurysms

1804.1 Epidemiology and indications for treatment F. Thony (Grenoble/FR) 1804.2 How should we treat aneurysms of the main SMA

or the celiac trunk? L.P. Lawler (Dublin/IE) 1804.3 How should we treat aneurysms involving the

pancreaticoduodenal arcade? P.P. Goffette (Brussels/BE) 1804.4 Is there a role for flow diverting stents? F. Fanelli (Rome/IT)


Which treatment should we use? – 3cm HCC

1805.1 Surgery J. Fuster Obregón (Barcelona/ES) 1805.2 Alcohol K. Malagari (Athens/GR) 1805.3 RFA L. Bianchi Cardona (Barcelona/ES) 1805.4 Microwave M. Kuang (Guangzhou/CN) 1805.5 TACE and drug-eluting beads Y. Arai (Tokyo/JP) 1805.6 Irreversible electroporation G. Narayanan (Miami, FL/US) 1805.7 Moderator’s summary and discussion

10:30-12:30 VAT-HoW 2 Hands-on Workshop Vertebral augmentation techniques /

vertebroplasty & kyphoplasty


11:15-12:45 EMT-HoW 2 Hands-on Workshop Embolization: materials and tools /

coils & plugs


11:15-12:45 RD-HoW 2 Hands-on Workshop Renal denervation

Coordinators: F. Fanelli (Rome/IT), G.S. Goh (London/UK)




40 The Wave of InnovationMonday, September 16

C RSE

Monday, September 16Barcelona 2013 41


18:00-19:00 WS 2301 Workshop Advanced endoleak management

2301.1 R.G. McWilliams (Liverpool/UK) 2301.2 F. Pozzi-Mucelli (Trieste/IT)

18:00-19:00 WS 2302 Workshop Interventions for chylothorax and

chylous ascites

2302.1 S.M. Lyon (Melbourne, VIC/AU) 2302.2 M. Itkin (Philadelphia, PA/US)

18:00-19:00 WS 2303 Workshop How to start your vascular

malformation practice

2303.1 L.J. Schultze Kool (Nijmegen/NL) 2303.2 Y.-S. Do (Seoul/KR)

18:00-19:00 WS 2304 Workshop Metastatic bone disease – embolization,

cemen toplasty and ablation: case-based discussions

2304.1 A. Manca (Candiolo/IT) 2304.2 S. Masala (Rome/IT)

18:00-19:00 WS 2305 Workshop Musculoskeletal ultrasound-guided

procedures

2305.1 P. Peetrons (Brussels/BE) 2305.2 H. Guerini (Paris/FR)

18:00-19:00 WS 2306 Workshop Palliation in interventional oncology

(pleural effusions, ascites, pain, etc)

2306.1 E. Alexopoulou (Athens/GR) 2306.2 G.J. Munneke (London/UK)


12:45-14:15 TA-HoW 5 Hands-on Workshop Tumour ablation: tips and tricks / lung



13:00-14:30 General Assembly


15:30-16:30 FI 2101 Film Interpretation Quiz

Coordinators: S. Macdonald (Newcastle-upon-Tyne/UK), O.M. van Delden (Amstderdam/NL)

16:00-17:30 EMT-HoW 3 Hands-on Workshop Embolization: materials and tools /

liquid agents


16:30-18:00 ST-HoW 1 Hands-on Workshop Stroke therapy

Coordinators: J. Berkefeld (Frankfurt/DE), H. van Overhagen (The Hague/NL)




C RSE

Tuesday, September 17


08:30-09:30 SS 2501 Special Session New platforms/agents for drug delivery

2501.1 Thermally sensitive doxorubicin carriers R. Lencioni (Pisa/IT) 2501.2 Chemosaturation B.J. Wood (Bethesda, MD/US) 2501.3 HIFU-assisted drug delivery A. Melzer (Dundee/UK) 2501.4 Percutaneous intratumoural viral therapy S.C. Rose (San Diego, CA/US)

08:30-09:30 SS 2502 Special Session Surveillance after aortic endografting

2502.1 Optimal imaging strategy post EVAR R. Iezzi (Rome/IT) 2502.2 Predicting reintervention rates after EVAR for AAA:

do all patients need the same surveillance? M. Thompson (London/UK) 2502.3 Do we need plain abdominal radiographs post EVAR? R.G. McWilliams (Liverpool/UK) 2502.4 Post TEVR – does everybody need CTA forever? G. Rosen (Tel Aviv/IL)

08:30-09:30 SS 2503 Special Session Trauma

2503.1 Renal trauma S. Park (Daejeon/KR) 2503.2 Mesenteric and hepatic vascular trauma J. Golzarian (Minneapolis, MN/US) 2503.3 Supra-aortic arterial trauma P.K. Ellis (Belfast/UK) 2503.4 Lower extremity arterial trauma C. De Vries (Bloemfontein/ZA)

08:30-09:30 ICS 2504 Interactive Case Session Acute and chronic low back pain

2504.1 A.D. Kelekis (Athens/GR) 2504.2 W.A. Clark (Kogarah, NSW/AU)

08:30-09:30 ICS 2505 Interactive Case Session Ischaemic stroke management –

problems and solutions

2505.1 T. Andersson (Stockholm/SE) 2505.2 T. Liebig (Köln/DE)

08:30-10:00 VV-HoW 2 Hands-on Workshop Varicose veins

Coordinators: C.A. Binkert (Winterthur/CH), K.D. McBride (Dunfermline/UK)


skills training / emergency embolization: trauma and other haemorrhagic emergencies




Which treatment should we use? – Colorectal liver metastases

2601.1 Surgery S. López-Ben (Girona/ES) 2601.2 RFA A. Gillams (London/UK) 2601.3 Microwave L. Solbiati (Busto Arsizio/IT) 2601.4 TACE and drug-eluting beads F. Orsi (Milan/IT) 2601.5 Radioembolization R. Salem (Chicago, IL/US) 2601.6 Intra-arterial chemotherapy T. de Baère (Villejuif/FR) 2601.7 Irreversible electroporation M.E. Hicks (Houston, TX/US) 2601.8 Moderator’s summary and discussion

42 The Wave of InnovationTuesday, September 17

Tuesday, September 17Barcelona 2013 43

10:30-12:30VAT-HoW 3 Hands-on Workshop Vertebral augmentation techniques /

vertebroplasty & stentoplasty


11:15-12:45RD-HoW 3 Hands-on Workshop Renal denervation

Coordinators: F. Fanelli (Rome/IT), G.S. Goh (London/UK)

11:15-12:45 EMT-HoW 4 Hands-on Workshop Embolization: materials and tools / liquid agents



13:00-14:30 Josef Roesch Lecture / Hot Topic Symposium

HL 2801 Josef Roesch Lecture

2801.1 High-intensity focused ultrasound: an IR tool for the future?

M. Bezzi (Rome/IT)

HTS 2802 Treatment of lung cancer – the choices, and how to make them

2802.1 The role of imaging in guiding the treatment of lung cancer

J. Vilar (Valencia/ES) 2802.2 Thermal ablation: research or mainstream therapy? T. de Baère (Villejuif/FR) 2802.3 Percutaneous cryotherapy in the lungs and the

thoracic wall A. Gangi (Strasbourg/FR) 2802.4 Radiation therapy: the oncologist’s view of how to

choose whether and how to treat L.M. Kenny (Brisbane, QLD/AU)

14:45-16:15 ST-HoW 2 Hands-on Workshop Stroke therapy

Coordinators: J. Berkefeld (Frankfurt/DE), H. van Overhagen (The Hague/NL)

10:00-11:00 SS 2602 Special Session Controversies in endoleak management

2602.1 There is sufficient evidence to treat type 2 endoleaks post EVAR: Pro

M. Černá (Olomouc/CZ) 2602.2 There is sufficient evidence to treat type 2

endoleaks post EVAR: Con S. Müller-Hülsbeck (Flensburg/DE) 2602.3 EVAR: Type 2 endoleaks should be treated by

direct sac puncture embolization H. Kobeiter (Créteil/FR) 2602.4 EVAR: Type 2 endoleaks should be treated by

transarterial embolization K. Schürmann (Dortmund/DE) 2602.5 TEVR: Type 2 endoleaks require treatment: Pro J.C. van den Berg (Lugano/CH) 2602.6 TEVR: Type 2 endoleaks require treatment: Con M. Thompson (London/UK)

10:00-11:00 SS 2603 Special Session Acute deep venous thrombosis

2603.1 Lower limb DVT – which patients should we treat and how?

H.-J. Wagner (Berlin/DE) 2603.2 Upper limb DVT – which patients should we treat

and how? V. Bérczi (Budapest/HU) 2603.3 What is the true benefit of thrombectomy devices

in acute upper and lower limb DVT? M. Rodière (Grenoble/FR) 2603.4 Is there a role for lysis and IVC filters in paediatric DVT? S. Sierre (Buenos Aires/AR)

10:00-11:00 ICS 2604 Interactive Case Session Biliary obstruction and acute pancreatitis

2604.1 A. Keeling (Dublin/IE) 2604.2 A.R. van Erkel (Leiden/NL)

10:00-11:00 CM 2605 CIRSE Meets CIRSE meets Singapore

Moderators: K.-H. Tay (Singapore/SG), M.J. Lee (Dublin/IE)

2605.1 IR management of ultra-large hepatocellular carcinomas U. Pua (Singapore/SG) 2605.2 Haemodialysis access interventions –

randomised trials from Singapore F.G. Irani (Singapore/SG) 2605.3 “Angioplasty first” approach to critical limb ischaemia A. Gogna (Singapore/SG)

14:45-16:15 TA-HoW 6 Hands-on Workshop Tumour ablation: tips and tricks / kidney


15:00-16:00 Satellite Symposia 16:00-17:30 EMT-HoW 5 Hands-on Workshop Embolization: materials and tools /

particulate agents


16:15-17:15 AI 3001 Amazing Interventions 16:15-17:15 SS 3002 Special Session Clinical practice – lower limb

3002.1 How can IRs provide total management of the patient with PAD?

J.A. Reekers (Amsterdam/NL) 3002.2 Non-imaging assessment of the patient with PAD:

essentials H. Alfke (Lüdenscheid/DE) 3002.3 Peri- and postprocedural coagulation management A.A. Nicholson (Leeds/UK) 3002.4 Can you explain outcome measures in

peripheral interventions? J. Lammer (Vienna/AT)

16:15-17:15 SS 3003 Special Session New horizons in musculoskeletal interventions

3003.1 MR-guided interventions A. Gangi (Strasbourg/FR) 3003.2 Percutaneous screw fixation of fractures and

imminent fractures N. Amoretti (Nice/FR) 3003.3 What’s new in tumour management? G.C. Anselmetti (Turin/IT) 3003.4 Hybrid interventions: surgery and IR S.M. Tutton (Milwaukee, WI/US)

16:15-17:15 SS 3004 Special Session High-intensity focused ultrasound

3004.1 How much ablation do you need in uterine fibroids? M. Matzko (Dachau/DE)

3004.2 Morphological and anatomical inclusion criteria for the treatment of painful bone metastases

W.M. Gedroyc (London/UK) 3004.3 Prostate cancer: focal tumour ablation or total

gland ablation? A. Napoli (Rome/IT) 3004.4 Technical advances for breast tumours M. van den Bosch (Utrecht/NL)

17:30-18:30 WS 3101 Workshop TIPS and BRTO: case-based discussions

3101.1 S. Punamiya (Singapore/SG) 3101.2 K. Kichikawa (Nara/JP)

17:30-18:30 WS 3102 Workshop Advanced dialysis graft and fistula management

3102.1 M. Katoh (Krefeld/DE) 3102.2 S.O. Trerotola (Philadelphia, PA/US)

17:30-18:30 WS 3103 Workshop Advanced vascular malformation management:


3103.1 P. Waldenberger (Linz/AT) 3103.2 A.M. Cahill (Philadelphia, PA/US)

17:30-18:30 WS 3104 Workshop Non-vascular renal interventions:


3104.1 M.K. Glynos (Athens/GR) 3104.2 A.G. Ryan (Waterford City/IE)

17:30-18:30 WS 3105 Workshop Portal vein embolization: what you need to know

3105.1 A. Denys (Lausanne/CH) 3105.2 K.P. van Lienden (Amsterdam/NL)

17:30-18:30 WS 3106 Workshop ABC of varicose vein ablation

3106.1 L. Oguzkurt (Adana/TR) 3106.2 M. Åkesson (Malmoe/SE)


44 The Wave of InnovationTuesday, September 17

Wednesday, September 18Barcelona 2013 45

09:45-10:45 SS 3302 Special Session IR after surgical disasters

3302.1 Complications of bariatric surgery (weight-loss surgery)

M. Corona (Rome/IT) 3302.2 IR in complications after

laparoscopic cholecystectomy K. Güven (Istanbul/TR) 3302.3 IR after urologic procedures or

nephron-sparing surgery P.J. Haslam (Newcastle-upon-Tyne/UK) 3302.4 IR after Whipple’s duodenopancreatectomy O.M. van Delden (Amsterdam/NL)

09:45-10:45 ICS 3303 Interactive Case Session EVAR and TEVR complications

3303.1 L. Lönn (Copenhagen/DK) 3303.2 H. Rousseau (Toulouse/FR)

09:45-10:45 SS 3304 Special Session New clinical applications for

interventional oncologists 2

3304.1 Adrenal tumours P.A.M.S. Almeida (Viseu/PT) 3304.2 GIST P.L. Pereira (Heilbronn/DE) 3304.3 Prostate cancer J.J. Fütterer (Nijmegen/NL) 3304.4 Thyroid tumours J.H. Baek (Seoul/KR)

11:00-12:30 MM 3401 Morbidity & Mortality Conference

and Closing

Coordinators: M. Krokidis (London/UK), R. Uberoi (Oxford/UK)

Wednesday, September 18

08:30-09:30 WS 3201 Workshop Acute limb ischaemia: case-based discussions

3201.1 J.M. Pulido-Duque (Las Palmas de Gran Canaria/ES) 3201.2 H.-J. Wagner (Berlin/DE)

08:30-09:30 WS 3202 Workshop ABC of erectile dysfunction

3202.1 L. Machan (Vancouver, BC/CA) 3202.2 N. McEniff (Dublin/IE)

08:30-09:30 WS 3203 Workshop How to pass the EBIR

3203.1 K.A. Hausegger (Klagenfurt/AT) 3203.2 R. Uberoi (Oxford/UK)

08:30-09:30 WS 3204 Workshop Radioembolization: what you need to know

3204.1 T.F. Jakobs (Munich/DE) 3204.2 A. Martínez de la Cuesta (Pamplona/ES)

09:45-10:45 SS 3301 Special Session Controversies in vascular intervention

3301.1 BTK occlusion – after a failed antegrade attempt, transpedal access should be attempted before fem-distal bypass: Pro

K.N. Katsanos (London/UK) 3301.2 BTK occlusion – after a failed antegrade attempt,

transpedal access should be attempted before fem-distal bypass: Con

R.J. Hinchliffe (London/UK) 3301.3 Patients with lifestyle limiting claudication should

be treated by exercise therapy before angioplasty: Pro

M.J.W. Koelemaij (Amsterdam/NL) 3301.4 Patients with lifestyle limiting claudication should

be treated by exercise therapy before angioplasty: Con

T. Jahnke (Neumünster/DE) 3301.5 There is enough evidence to justify lysis/

thrombectomy for acute iliofemoral DVT: Pro B. Gebauer (Berlin/DE) 3301.6 There is enough evidence to justify lysis/

thrombectomy for acute iliofemoral DVT: Con J. Kettenbach (Bern/CH)


Hands-on Workshops

A closer look at closure devicesCoordinators: S. Müller-Hülsbeck (Flensburg/DE), J. Tacke (Passau/DE)

Vascular closure devices (VCDs) are commonly utilised to man age arterial puncture sites after therapeutic arterial interventions.

This hands-on workshop will introduce and discuss VCDs cur rently available on the market in a comprehensive and balanced manner, including indications for use, optimal tech-nique, contraindications as well as potential complications and their management. Furthermore, many tips and tricks for pro-per use of closure devices during daily practice will be shared during the hands-on part. The course will be completed by a dedicated tutorial of the “preclose” technique for closing large arterial punctures for total percutaneous aortic repair.

By the end of the workshop all participants should be able to understand the various principles and indications of current de-vices, completed by the opportunity of extensive sample testing.

Learning objectives– To become familiar with the current available vascular

closure devices for peripheral and aortic interventions – To understand when and how to successfully use a vascular

closure device– To know when not to use a vascular closure device and

how to avoid complications– To gain experience with the “preclose” technique required

for total percutaneous treatment of aortic aneurysms

CD-HoW 1 Saturday, September 14 17:00-18:30

CD-HoW 2 Sunday, September 15 17:00-18:30

CD-HoW 3 Monday, September 16 17:00-18:30

Please note that participants need to register in advance at an extra cost of € 75.

Embolization: materials and toolsCoordinators: S.J. McPherson (Leeds/UK), E.M. Walser (Galveston, TX/US)

This series of hands-on workshops provides an overview of current embolization materials and techniques.

In each workshop session a brief introduction is followed by partici pants rotating around 4 to 6 tabletop demonstrations. The workshops may be attended as a series or individually. Partici pants will engage informally with instructors and try out various embolic materials on anatomical and flow models.The emphasis of the sessions is a hands-on practical approach. Participants can handle and/or perform embolization with mechanical, liquid or particulate embolic agents (according to the session). The focus is on those with limited experience with embolization or those wishing to refresh their knowledge.

Learning objectives– To understand the basic principle of embolization– To become familiar with the common embolic agents– To be able to choose an appropriate embolic agent– To know how to correctly prepare and deliver the chosen agent– To understand how to avoid non-target embolization and

other complications

EMT-HoW 1 Sunday, September 15Coils & plugs 16:00-17:30

EMT-HoW 2 Monday, September 16Coils & plugs 11:15-12:45

EMT-HoW 3 Monday, September 16Liquid agents 16:00-17:30

EMT-HoW 4 Tuesday, September 17Liquid agents 11:15-12:45

EMT-HoW 5 Tuesday, September 17Particulate agents 16:00-17:30


46 The Wave of InnovationHands-on Workshops

IVC filtersCoordinators: O. Pellerin (Paris/FR), A.F. Watkinson (Exeter/UK)

IVC filters are widely used in Europe. They all have pros and cons regarding technical features that make them more or less difficult to retrieve or convert.

The workshop will start with a 15-minute introduction focused on the technical features of the filters available in the room. Participants will then have the opportunity to test the filters on models, with the help of experts who will be on hand. This workshop is aimed at vascular IRs who perform IVC filter place-ment and want to learn the specific techniques of filter extraction and conversion.

Learning objectives– To learn the basic technical features of IVC filters and be able

to choose an appropriate device– To practise the step-by-step technique for implantation and

extraction/conversion– To learn technical tips and tricks

IVC-HoW 1 Saturday, September 14 12:45-14:15

IVC-HoW 2 Sunday, September 15 12:45-14:15

IVC-HoW 3 Monday, September 16 12:45-14:15


Hands-on Workshops

Principles to practice: education and simulation skills training


This popular series of workshops uses a round table discussion format with topic experts to deliver key knowledge and practical tips followed by practice with the aid of high fidelity simulators.

Each session is aimed at delegates with a specific level of ex perience (core, intermediate or advanced). The round-table discussions are themed around learning objectives which relate to a specific clinical or procedural topic.

The delivery of each session is flexible to respond to delegates’ interests, and emphasis is placed on small group teaching allow-ing close interaction with the expert faculty. Equipment and de-vices will be available to demonstrate deployment technique.

PTP-HoW 1 Saturday, September 14 Renal denervation 08:30-13:00

PTP-HoW 2 Sunday, September 15Peripheral vascular 08:30-13:00disease: getting better outcomes in limb ischaemia

PTP-HoW 3 Monday, September 16Emergency EVAR: 08:30-13:00assessment and deployment

PTP-HoW 4 Tuesday, September 17Emergency embolization: 08:30-13:00trauma and other haemorrhagic emergencies


Barcelona 2013 47


Renal denervationCoordinators: F. Fanelli (Rome/IT), G. Goh (London/UK)

Transcatheter renal denervation is a novel therapy for pa-tients with treatment resistant hypertension, a condition that leads to a higher risk of major cardiovascular events.

In this workshop an overview of sympathetic nervous system anatomy, physiology and physiopathology will be followed by a description of the technical aspects of renal denervation.

During the hands-on part of the course participants will learn how to use currently available devices in order to become fami liar with the procedure and be able to compare their characteristics.

Experienced tutors will be present in an informal setting to discuss technical tips and tricks, getting you ready to start your renal denervation practice.

Learning objectives– To understand the disease of treatment-resistant hypertension

and its relationship with the sympathetic nervous system– To receive the latest research data– To understand the principles of patient selection– To learn how to start a practice in renal denervation– To understand the technical aspects of renal denervation– To be familiar with the principles and handling of a selection

of devices

RD-HoW 1 Saturday, September 15 11:15-12:45

RD-HoW 2 Monday, September 16 11:15-12:45

RD-HoW 3 Tuesday, September 17 11:15-12:45


Stroke therapyCoordinators: J. Berkefeld (Frankfurt/DE), H. van Overhagen (The Hague/NL)

An increasing number of interventional radiologists are involved in intra-arterial therapy for acute cerebral stroke. There is increasing evidence that urgent restoration of cerebral circulation by mechanical thrombectomy is one of the most important factors determining the fate of patients with acute ischaemic stroke.

In this workshop participants will have the opportunity to test several devices specifically designed for intracranial throm-bectomy on a flow model under the supervision of well recognised experts in the field.

Learning objectives– To introduce the principles of mechanical thrombectomy in

patients with embolic stroke– To get to a standardised technique in a step-by-step manner– To become familiar with four typical devices and their

handling– To get an impression of how it works from training with the

flow model– To discuss technical and clinical problems with co-ordinators

and instructors

ST-HoW 1 Monday, September 16 16:30-18:00

ST-HoW 2 Tuesday, September 17 14:45-16:15



nEW

Hands-on Workshops

Tumour ablation: tips and tricksCoordinators: T.K. Helmberger (Munich/DE), A.D. Kelekis (Athens/GR)

The hands-on workshop on tumour ablation is one of the most practical teaching sessions included in the CIRSE programme.

The workshop provides 6 sessions which include introductory interactive case discussions and practical training upon the ba sic principles of all current ablation systems. The case dis-cussions will highlight indications-contraindications as well as com plications and ways to avoid or minimise them.

Participants will then have the opportunity to get familiar with the equipment and the procedure itself, to practice ablation using various systems under the guidance of international ablation experts and to perform ultrasound-guided ablation on in vitro models.

By the end of the workshop participants, even those with little or no experience in tumour ablation, will be familiar with a range of ablation techniques and be aware of tips and tricks for safe and efficacious clinical application.

TA-HoW 1 Saturday, September 14Starting your practice 12:45-14:15

TA-HoW 2 Saturday, September 14Starting your practice 16:00-17:30

Learning objectives– To understand the basic principles of the various ablation

techniques and to get familiar with the technical intricacies of the various systems

– To understand the importance of an interdisciplinary tumour board for selecting the most appropriate therapy

– To get familiar with potential technique and patient specific contraindications and risk factors

– To get familiar with ultrasound-guided ablation

TA-HoW 3 Sunday, September 15Liver 12:45-14:15

Learning objectives– To understand the most appropriate indications for hepatic

tumour ablation according to present guidelines – To know how to choose the right ablation technique for

each lesion– To understand the liver contraindications for local

ablation techniques– To understand how to enhance the efficacy of a specific ab -

lation technique by adjuvant techniques and how to minimise or avoid the most commonly encountered complications

– To get familiar with ultrasound-guided liver ablation

TA-HoW 4 Sunday, September 15Bone and soft tissue 16:00-17:30

Learning objectives– To understand the most appropriate indications for bone

tu mour ablation according to present guidelines as well as to know how to choose the right ablation technique for each lesion

– To understand the bone contraindications for local ablation techniques

– To understand how to enhance the efficacy of a specific ab-lation technique by adjuvant techniques and how to avoid or minimise the most commonly encountered complications

– To get familiar with ultrasound-guided soft-tissue ablation

TA-HoW 5 Monday, September 16Lung 12:45-14:15

Learning objectives– To understand the most appropriate indications for lung tu mour

ablation according to present guidelines as well as to know how to choose the right ablation technique for the right lesion

– To understand the liver contraindications for local ablation techniques

– To understand how to enhance the efficacy of a specific ab -lat ion technique by adjuvant techniques and how to minimise or avoid the most commonly encountered complications

TA-HoW 6 Tuesday, September 17 Kidney 14:45-16:15

– To understand the most appropriate indications for renal tu mour ablation according to present guidelines as well as to know how to choose the right ablation technique for each lesion

– To understand how to enhance the efficacy of a specific ab-lation technique by adjuvant techniques and how to avoid or minimise the most commonly encountered complications

– To get familiar with ultrasound-guided renal ablation


Barcelona 2013 49

Varicose veinsCoordinators: C.A. Binkert (Winterthur/CH), K.D. McBride (Dunfermline/UK)

Endovenous treatment of symptomatic varicose veins has become more and more accepted throughout Europe. In many countries these treatments are or will be reimbursed by insurance companies. Interventional radiologists are well suited to perform these therapies as they have the requir ed skill-set, which includes patient evaluation, diag-nostic duplex ultrasound, venous access under ultrasound guidance and catheter-based intervention. unfortunately many IRs are not yet familiar with the available techniques and devices.

This hands-on workshop gives an opportunity to gain familiar-ity with the most commonly used techniques and devices for endovenous therapy, including the handling of different fibres and probes and the corresponding generators. Participants will learn how to best access the vein with ultrasound guidance, how to apply tumescent anaesthesia and how to use the appropriate devices. In addition there will be the opportunity to gain insightful advice from expert users.

Learning objectives– To learn about the different methods for endovenous therapies– To obtain practical experience with different devices– To receive hands-on training in ultrasound-guided

venous access– To learn the technique of tumescent anaesthesia

VV-HoW 1 Sunday, September 15 08:30-10:00

VV-HoW 2 Tuesday, September 17 08:30-10:00


Vertebral augmentation techniquesCoordinators: J. Garnon (Strasbourg/FR), G. Tsoumakidou (Strasbourg/FR)

Percutaneous vertebroplasty is a technique in which acry lic cement is injected through a needle into a collap-sed or weakened vertebra. This procedure is effective for treating certain types of painful vertebral compression fractures and some painful or unstable benign and malignant verte bral lesions which fail to respond to conservative therapies.

Kyphoplasty is an adaptation of vertebroplasty. High pressure balloons are inserted into the vertebral bodies and enable the creation of a cavity into which cement can be safely injected. Stentoplasty is a further recently developed adaptation which involves placing two metallic stents (cages) within the collap-sed vertebral body and to expand them. The main goal of stentoplasty is to restore the vertebral body height before cementation.

As in past CIRSE congresses, this workshop will give an insight into the principles and techniques of above-mentioned pro-cedures. It will start with a theoretical introduction and a brief review of the principles and indications. This will be followed by a hands-on demonstration. Participants will have the opportunity to practice needle placement, cement prepara-tion and injection on plastic spine models under fluoroscopic guidance.

Learning Objectives– To understand the basic principles of the procedures– To get familiar with the currently available vertebral

augmentation techniques – To practise needle placement on a lumbar vertebral body

model under fluoroscopic guidance– To learn and practise cement preparation and delivery under

fluoroscopic guidance– To learn how to perform kyphoplasty/stentoplasty


C RSE

Hands-on Workshops

VAT-HoW 1 Sunday, September 15Vertebroplasty 10:30-12:30

VAT-HoW 2 Monday, September 16Vertebroplasty 10:30-12:30& kyphoplasty VAT-HoW 3 Tuesday, September 17Vertebroplasty 10:30-12:30& stentoplasty


Barcelona 2013 51

Barcelona 2013 | Annual Meeting and Postgraduate Course

E D u C A T I O N I N I N T E R V E N T I O N A L R A D I O L O G y

Did you know that ESIRonline contains more than 5,800 presentations from all areas of interventional radiology?

CIRSE members benefit from year-round access to the complete lecture database on ESIRonline.

uwww.esir.org ... Interventional Radiology at your fingertips

Course ProgrammeStroke Intervention (Level 4/Advanced)April 12-13, 2013 Klagenfurt / AT

Embolisation (Level 2-3/Intermediate) April 19-20, 2013Odense / DK

Biopsies & Drainage Procedures (Level 1/Basic) May 24-25, 2013Ankara / TR

Musculoskeletal Interventions (Level 1/Basic) June 7-8, 2013 Athens / GR

Lung Interventions: Embolisation & Ablation (Level 4/Advanced) July 5-6, 2013 Frankfurt / DE

Management of Resistant Hypertension: Renal Artery Denervation (Level 4/Advanced) October 18-19, 2013 Rome / IT

Tumour Ablation (Level 1/Basic) November 8-9, 2013Lausanne / CH

Peripheral Arteries & Lower Extremities (Level 1/Basic) November 15-16, 2013 Amsterdam / NL

European School of Interventional Radiology

ESIR 2013

C RSE f o u n d a t i o n

In 2013, the CIRSE Foundation will organise eight local courses in different university hospitals around Europe

For more information on upcoming ESIR courses, please contact [email protected]

Cardiovascular and Interventional Radiological Society of Europe

General Information

DatesCIRSE 2013 will take place September 14-18, 2013.

VenueCCIBPlaça de Willy Brandt 11-1408019 BarcelonaSpain

CME Credit AllowanceEuropean Accreditation will be applied for at the EACCME (European Accreditation Council for Continuing Medical Education) in order to validate the credits in CIRSE participants’ European home countries. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net.

All CME activities approved by the EACCME are valid for rec-ognition by the American Medical Association (AMA) towards the Physician‘s Recognition Award (PRA). For details how to convert EACCME credits to AMA PRA category 1 credits, please contact the AMA (www.ama-assn.org). Live educational activi-ties occurring outside of Canada and recognised by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada.

CIRSE 2012 in Lisbon, Portugal, was granted 27 hours of European external CME credits.

CIRSE Central Office Neutorgasse 9/61010 ViennaAustriaPhone: +43 1 9042003Fax: +43 1 9042003 30E-mail: [email protected]

General Information

Hotel and Travel BookingIn cooperation with its travel partner Kuoni DMC, CIRSE has secured a great number of hotel rooms in Barcelona for the benefit of our congress participants.Online hotel reservation is now available at www.cirse.org.

If you have any questions, please do not hesitate to contact:Kuoni Destination Managementyour contact: Ivan MuñozCalle Pau Claris, 138, 1a 3a

08009 BarcelonaSpainPhone: +34 902 060026 or +34 93 5052510Fax: +34 93 4883703E-mail: [email protected]

Booking ConditionsRooms will be allocated on a “first come – first served” basis. A one night deposit per reserved room is required to secure your hotel reservation. All payments are requested to be made in Euro (€). Bank fees will be charged to the participant. Please note, that your payment must reach Kuoni DMC no later than 10 days after booking, otherwise your reservation will be cancelled.

Group Requests (10 rooms and more):For group bookings please send your request directly to KUONI, Mr Ivan Muñoz under [email protected]

Cancellation PolicyPlease note the following cancellation policy which will apply to all individual hotel bookings:

Cancellations until July 1, 2013:100% refund less € 25 handling feeCancellation between July 2, 2013 and July 31, 2013:1 night cancellation fee will apply.Cancellation received from August 1, 2013 onwards:No refund can be made, 100% cancellation fee will apply on full stay.

No shows: Your hotel room will be cancelled after first night of no show and the full amount of your stay will be charged.

• All cancellations and changes are to be addressed to Kuoni DMC in writing.

• For changes Kuoni DMC reserves the right to charge an administration fee.

• Please note that accommodation for additional nights is strictly subject to the hotel’s availability.

• All necessary refunds will be made after the congress.

Barcelona 2013 53


Submit your manuscript to a global audience!

To submit a manuscript, please visit: http://mc.manuscriptcentral.com/cvr

CVIR is the official journal of:

Austrian Society of Interventional Radiology (ÖGIR) Brazilian Society of Interventional Radiology and Endovascular Surgery (SoBRICE) British Society of Interventional Radiology (BSIR) Chinese Society of Interventional Radiology (CSIR) Czech society of Interventional Radiology (CSIR)Danish Society of Interventional Radiology (DFIR) Dutch Society of Interventional Radiology (NGIR) Finnish Society of Interventional Radiology (FSIR) German Society of Interventional Radiology (DeGIR) Indian Society of Vascular and Interventional Radiology (ISVIR) Interventional Radiology Section of the Polish Medical Society of Radiology (PLTR) Israeli Society of Interventional Radiology (ILSIR)Japanese Society of Interventional Radiology (JSIR) Korean Society of Interventional Radiology (KSIR) Russian Society of Interventional Onco-Radiology (SIOR) Swiss Society of Cardiovascular and Interventional Radiology (SSCVIR)Turkish Society of Interventional Radiology (TGRD)

CardioVascular and Interventional Radiology

v o l 35n o 2a p r i l

2 0 1 2RCVT h e o f f i c i a l j o u r n a l o f t h e C a r d i o v a s c u l a r a n d I n t e r v e n t i o n a l R a d i o l o g i c a l S o c i e t y o f E u r o p e

00270 • ISSN 0174-1551 35(2) 223-444 (2012)

Springer

CVIR‘S NEW IMPACT FACTOR2.093

RegistrationBarcelona 2013 55


Online registration (secured payment) for CIRSE 2013 is nowavailable on www.cirse.org. Please note that your registrationmust be submitted and all fees paid by the respective deadlines.Incomplete registrations (not containing full name and address) cannot be processed.

Registration Fees (€)

until June 6, 2013CIRSE Member € 420Non Member € 720Resident* (CIRSE Member) € 270 Resident* (Non Member) € 320Nurse/Radiographer* (CIRSE Member) € 190Nurse/Radiographer* (Non Member) € 300 Undergraduate Student** € 0

until July 11, 2013CIRSE Member € 580Non Member € 895Resident* (CIRSE Member) € 455 Resident* (Non Member) € 520Nurse/Radiographer* (CIRSE Member) € 290Nurse/Radiographer* (Non Member) € 400 Undergraduate Student** € 0

After July 11, 2013CIRSE Member € 675Non Member € 970Resident* (CIRSE Member) € 475 Resident* (Non Member) € 550Nurse/Radiographer* (CIRSE Member) € 440Nurse/Radiographer* (Non Member) € 550 Undergraduate Student** € 0

* to be accompanied by a certificate signed by the Head of Department

** for undergraduate medical students. Students’ registrations must be accompanied by a certificate or letter from the university, confirming the undergraduate medical student status and by a copy of a valid ID.

Reduced registration fees for CIRSE 2013 are only available for members who have been in good standing during the years 2012 and 2013 (individuals who become CIRSE members in 2013 will be able to benefit from reduced congress fees for the meeting in 2014).

Method of paymentRegistration fees are to be paid in Euros (€) by:• Bank Transfer or• Credit Card (Visa or Eurocard/Mastercard)

Cancellation of congress registrationCIRSE offers all participants the possibility of taking out cancel-lation insurance with our partner “Europäische Reiseversiche-rung” (see www.cirse.org). CIRSE will not provide refunds after a cancellation of registration. All requests for refund have to be issued to the „Europäische Reiseversicherung“.

Name changes will be handled as a cancellation and new registration.

Additional informationAll CIRSE 2013 registrants will be able to print out an invoice of the registration using their personal log-in details atwww.cirse.org.

Invoices will be issued by:CIRSE Congress Research Education GmbH,Neutorgasse 9, 1010 Vienna, Austria

Registration fee deemed as VAT exempt based on article 20 of the Spanish VAT Law 37/1992.

Congress Registration

Register before June 6, 2013 and benefit from reduced early bird registration fees!

Further information on hotel booking and registration is available at www.cirse.org

Hotel List CIRSE 2013 Barcelona

Hotel Cat‘ Single (€) Double (€) Travel time Travel time Cost by (Double Room public transport taxi taxi (€) Single Use)

1 Le Meridien 5* 330 352 25 min 15 min 12 2 Majestic 5* 325 345 25 min 15 min 12 3 Pullman Barcelona Skipper 5* 230 255 15 min 10 min 7 4 AC Hotel Barcelona Forum 4* 219 244 1 min walk 1 min walk – 5 Attica 21 Barcelona Mar 4* 190 202 10 min 5 min 5 6 Ayre Caspe 4* 174 184 30 min 15 min 12 7 Barcelo Atenea Mar 4* 194 204 15 min 8 min 5 8 Barcelona Center 4* 248 267 30 min 20 min 14 9 Barcelona Princess 4* 210 232 2 min walk 2 min walk – 10 Barcelo Raval 4* 219 235 30 min 20 min 14 11 Catalonia Catedral 4* 243 265 20 min 15 min 12 12 Catalonia Plaza Cataluña 4* 190 210 25 min 20 min 14 13 Catalonia Ramblas 4* 220 240 25 min 20 min 14 14 Condes de Barcelona 4* 219 239 25 min 20 min 14 15 Confortel Barcelona 4* 193 209 15 min 10 min 7 16 Diagonal Zero 4* 215 236 2 min walk 2 min walk – 17 Front Maritim 4* 164 177 10 min 8 min 5 18 Gallery 4* 273 296 30 min 20 min 15 19 H10 Marina 4* 170 185 15 min 10 min 7 20 HCC St. Moritz 4* 215 248 20 min 20 min 15 21 Hesperia Del Mar 4* 189 206 15 min 8 min 5 22 Hilton Diagonal Mar 4* 255 286 3 min walk 3 min walk – 23 Icaria Barcelona 4* 193 209 15 min 10 min 7 24 ME Barcelona 4* 254 296 10 min 5 min 5 25 Murmuri Barcelona 4* 294 314 25 min 20 min 15 26 NH Calderon 4* 215 237 20 min 20 min 15 27 NH Podium 4* 187 204 20 min 15 min 12 28 Novotel Barcelona City 4* 201 223 15 min 10 min 6 29 Pere IV 4* 143 153 10 min 10 min 6 30 Pulitzer 4* 240 260 25 min 20 min 15 31 Euro Hotel Diagonal Port 4* 172 181 15 min 8 min 5 32 Regina 4* 240 260 25 min 20 min 15 33 Silken Diagonal 4* 204 219 15 min 10 min 6 34 Silken Ramblas 4* 219 273 25 min 20 min 15 35 TRYP Condal Mar 4* 187 198 15 min 10 min 6 36 Vincci Bit 4* 211 233 10 min walk 5 min 4 37 Vincci Maritimo 4* 211 233 10 min walk 5 min 4 38 1898 4* 292 316 25 min 15 min 12 39 Four Points by Sheraton Barcelona Diagonal 3* 149 157 15 min 10 min 6 40 HCC Montblanc 3* 176 204 15 min 15 min 12 41 HCC Open 3* 165 193 30 min 25 min 16 42 Holiday Inn Barcelona 22@ 3* 118 118 10 min 8 min 5 43 NH Diagonal Center 3* 143 153 10 min 10 min 6

All rates are in Euro (€), per room, per night, including breakfast & taxes.

56 The Wave of InnovationAccommodation

City Map

For more detailed information and online hotel booking, please visit www.cirse.org

City Map CIRSE 2013 Barcelona

Additional information

Barcelona tourism tax is not included in the room rates. The tourism tax is: € 2.48 per person per night in a 5* hotel € 1.21 per person per night in a 4* hotel € 0.72 per person per night in a 3* hotel

The tourism tax must be paid directly at the hotel, up to a maximum of 7 nights and 2 guests per room. Children under 16 are exempt. (Law 5/2012, 20 March, DOGC)

Barcelona 2013 57


2

1

3

45

6

7

8

9

10

11

1213

14

15 16

17

18

19

20

2122

23

24

25

26

2728

29

30

31

3233

34 35

36

37

38

3940

41

4243

CCIB-Centre de Convencions Internacional de Barcelona

Documents

September 14-18 Barcelona, Spain CIRSE 2013 · Programme highlights include: Evidence Forums – new sessions devoted to evidence-based medicine. Forum topics will include the management